flucytosine has been researched along with C gattii Infection in 368 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of flucytosine and amphotericin B is first choice treatment for active cryptococcosis." | 9.10 | Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome? ( Cogliati, M; Esposto, MC; Tortorano, AM; Viviani, MA, 2003) |
| "Flucytosine (5-FC) monotherapy for cryptococcosis is not advocated because drug resistance emerges during therapy." | 9.08 | Flucytosine monotherapy for cryptococcosis. ( Bennett, JE; Hospenthal, DR, 1998) |
| "To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis." | 9.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "One hundred ninety-four patients with cryptococcal meningitis were enrolled in a multicenter, prospective, randomized clinical trial to compare the efficacy and toxicity of four as compared with six weeks of combination amphotericin B and flucytosine therapy." | 9.06 | Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. ( Blackwelder, WC; Bowles, CA; Cloud, G; Craven, PC; Diasio, RB; Dismukes, WE; Fisher, JF; Gallis, HA; Gregg, CR; Kaplowitz, LG; Kaufman, L; Kerkering, TM; Medoff, G; Shadomy, S; Soong, S; Stamm, AM, 1987) |
| "3 mg/kg per day, plus flucytosine, 150 mg/kg per day, was performed with 194 patients with cryptococcal meningitis." | 9.06 | Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. ( Bowles, CA; Cloud, GA; Diasio, RB; Dismukes, WE; Espinel-Ingroff, A; Karam, GH; Shadomy, S; Stamm, AM, 1987) |
| "Therapeutic effectiveness of 5-fluorocytosine (5-FC), amphotericin B (Am B) and both in combined administration were retrospectively assessed and compared with one another in 28 patients with cryptococcal meningitis." | 9.04 | Comparison between 5-fluorocytosine, amphotericin B and the combined administration of these agents in the therapeutic effectiveness for cryptococcal meningitis. ( Ikemoto, H; Jimbow, T; Tejima, Y, 1978) |
| "We compared amphotericin B therapy for cryptococcal meningitis with a newer regimen containing both amphotericin B and flucytosine." | 9.04 | A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. ( Alling, DW; Bennett, JE; Bradshaw, M; Cate, TR; Cobbs, CG; Dismukes, WE; Duma, RJ; Fields, BT; Gallis, H; Haywood, H; Leonard, J; McGee, ZA; Medoff, G; Sande, MA; Warner, JF, 1979) |
| " Thus, the efficacy of amphotericin B and flucytosine in combination was investigated by mortality and fungal burden studies in a murine model of disseminated cryptococcosis using two clinical isolates of Cryptococcus neoformans, one susceptible and one resistant (i." | 7.73 | Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. ( Dannaoui, E; Dromer, F; Lortholary, O; Schwarz, P, 2006) |
| "A patient with thoracic cryptococcal osteomyelitis was treated successfully with the combination of fluconazole and flucytosine." | 7.71 | Successful treatment of cryptococcal osteomyelitis and paraspinous abscess with fluconazole and flucytosine. ( Cook, PP, 2001) |
| "Six cases (3 cats, 3 dogs) of cryptococcosis were cured using combination chemotherapy that included amphotericin B." | 7.69 | Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. ( Craig, AJ; Love, DN; Malik, R; Martin, P; Wigney, DI, 1996) |
| "The efficacy of the combination therapy of fluconazole plus flucytosine against pulmonary cryptococcosis was investigated." | 7.68 | [Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine]. ( Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S; Mitsutake, K; Miyazaki, H; Miyazaki, T; Tanaka, K; Tomono, K, 1993) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| " Cryptococcal meningitis is a common life-threatening infection in AIDS patients, usually treated with amphotericin B, often in combination with flucytosine." | 7.68 | Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. ( Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR, 1991) |
| "Experiments are described of the treatment of two patients with cryptococcal meningitis using antifungal drugs and amphotericin B." | 7.68 | Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B. ( Shindo, K, 1990) |
| "To assess the possible beneficial effects of combined therapy (fluconazole and flucytosine) in the treatment of cryptococcal meningitis in the immunocompromised host, we compared therapy with fluconazole and flucytosine, individually and combined, in the experimental murine model." | 7.68 | Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. ( Allendoerfer, R; Graybill, JR; Marquis, AJ; Rinaldi, MG, 1991) |
| "Ketoconazole, amphotericin B, 5-fluorocytosine, and combinations of these drugs were compared as therapy for chronic cryptococcal meningitis in steroid-treated rabbits." | 7.66 | Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. ( Durack, DT; Perfect, JR, 1982) |
| "The authors report a case of colitis, with anatomo-clinical confrontation, during a treatment with flucytosine." | 7.66 | [Iatrogenic colitis during flucytosine treatment for neuromeningeal cryptococcosis]. ( Bentata-Pessayre, M; Callard, P; Delzant, G; Dupont, B; Fond, B; Krivitzky, A, 1983) |
| "Flucytosine-associated diarrhea has been previously described in 6%-10% of patients receiving the drug." | 7.66 | Ulcerating enteritis associated with flucytosine therapy. ( Traube, J; White, CA, 1982) |
| "A 3-year-old girl in poor general condition was admitted with a diagnosis of cryptococcosis and treated with 5-fluorocytosine." | 7.66 | Cryptococcosis with cutaneous manifestations treated with 5-fluorocytosine. ( Kim, HJ; Lee, S, 1980) |
| "Results obtained in the treatment of cryptococcosis of the central nervous system with amphotericin-B, 5-fluorocytosine and miconazole are evaluated." | 7.66 | [Cryptococcosis of the central nervous system: evaluation of amphotericin-B, 5-fluorocytosine and miconazole therapy in 18 cases]. ( Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A, 1979) |
| "In a prospective study from May 1971 to November 1973, 20 consecutive patients with a diagnosis of disseminated cryptococcosis were treated for six weeks with a combination of amphotericin B (20 mg daily) intravenously and flucytosine (150 mg/kg daily) orally." | 7.65 | Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. ( Duma, RJ; Garriques, IL; Mandell, GL; McGehee, RF; Sande, MA; Shadomy, S; Utz, JP; Warner, JF, 1975) |
| "In patients with the acquired immunodeficiency syndrome (AIDS), the rate of relapse after primary treatment for cryptococcal meningitis remains high." | 6.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| " Fluconazole, at a dosage equivalent to 800 mg/day administered orally, and flucytosine, also given orally, led to a clinical response and a steady decline in serum cryptococcal antigen titer, which became negative at 6 weeks of therapy." | 5.30 | Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen. ( Gayowski, T; Marino, IR; Singh, N, 1998) |
| " Long term administration of amphotericin B (cumulative dose 5 g) combined with 5-flucytosine eradicated this fungal infection." | 5.28 | [A case of systemic lupus erythematosus associated with cryptococcal meningitis which was successfully cured by the administration of massive dose of amphotericin B]. ( Chida, Y; Hiruma, M; Ida, T; Makiguchi, K; Malumo, F; Matsuda, O; Tsutsui, H, 1990) |
| "Ketoconazole has been shown to penetrate into brain tissue of mice and cerebrospinal fluid of humans and to improve the course of human coccidioidal meningitis." | 5.27 | Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis. ( Craven, PC; Graybill, JR, 1984) |
| "The drugs used in the treatment of CNS cryptococcosis were, as possible, the amphotericin B by intravenous and intrathecal route (lumbar puncture) associated with 5-fluorocytosine." | 5.27 | [Amphotericin B in the treatment of neurocryptococcosis in patients subjected to renal transplantation]. ( Nóbrega, JP, 1988) |
| "The combination of flucytosine and amphotericin B is first choice treatment for active cryptococcosis." | 5.10 | Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome? ( Cogliati, M; Esposto, MC; Tortorano, AM; Viviani, MA, 2003) |
| "Flucytosine (5-FC) monotherapy for cryptococcosis is not advocated because drug resistance emerges during therapy." | 5.08 | Flucytosine monotherapy for cryptococcosis. ( Bennett, JE; Hospenthal, DR, 1998) |
| "To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis." | 5.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "One hundred ninety-four patients with cryptococcal meningitis were enrolled in a multicenter, prospective, randomized clinical trial to compare the efficacy and toxicity of four as compared with six weeks of combination amphotericin B and flucytosine therapy." | 5.06 | Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. ( Blackwelder, WC; Bowles, CA; Cloud, G; Craven, PC; Diasio, RB; Dismukes, WE; Fisher, JF; Gallis, HA; Gregg, CR; Kaplowitz, LG; Kaufman, L; Kerkering, TM; Medoff, G; Shadomy, S; Soong, S; Stamm, AM, 1987) |
| "3 mg/kg per day, plus flucytosine, 150 mg/kg per day, was performed with 194 patients with cryptococcal meningitis." | 5.06 | Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. ( Bowles, CA; Cloud, GA; Diasio, RB; Dismukes, WE; Espinel-Ingroff, A; Karam, GH; Shadomy, S; Stamm, AM, 1987) |
| "Therapeutic effectiveness of 5-fluorocytosine (5-FC), amphotericin B (Am B) and both in combined administration were retrospectively assessed and compared with one another in 28 patients with cryptococcal meningitis." | 5.04 | Comparison between 5-fluorocytosine, amphotericin B and the combined administration of these agents in the therapeutic effectiveness for cryptococcal meningitis. ( Ikemoto, H; Jimbow, T; Tejima, Y, 1978) |
| "We compared amphotericin B therapy for cryptococcal meningitis with a newer regimen containing both amphotericin B and flucytosine." | 5.04 | A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. ( Alling, DW; Bennett, JE; Bradshaw, M; Cate, TR; Cobbs, CG; Dismukes, WE; Duma, RJ; Fields, BT; Gallis, H; Haywood, H; Leonard, J; McGee, ZA; Medoff, G; Sande, MA; Warner, JF, 1979) |
| " While amphotericin B, usually in combination with flucytosine, generally is recommended as primary therapy for patients with severe forms of disease, especially cryptococcal meningitis, alternative treatment regimens have been developed or are under investigation." | 4.78 | Management of cryptococcosis. ( Dismukes, WE, 1993) |
| "A case of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) associated with pulmonary cryptococcosis which was successfully treated with fluconazole (FCZ) and flucytosine (5-FC) is described." | 4.78 | [A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan]. ( Kano, S; Minato, N; Saito, K; Saito, T; Saku, N; Sato, M; Suzuki, N; Takeda, A, 1993) |
| "Flucytosine (5-FC) is an antifungal agent commonly used for treatment of cryptococcosis and several other systemic mycoses." | 4.31 | Factors Influencing the Nitrogen-Source Dependent Flucytosine Resistance in Cryptococcus Species. ( Chang, YC; Khanal Lamichhane, A; Kwon-Chung, KJ; Yang, DH, 2023) |
| "Cryptococcus neoformans is an encapsulated yeast that can cause cryptococcosis and cryptococcal meningitis, which conventional treatment involves antifungal drugs such as polyenes, flucytosine, azoles, and their combinations." | 4.31 | Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans. ( de Menezes, RT; de Oliveira, HC; de Oliveira, LD; do Carmo, PHF; Junqueira, JC; Pereira, TC; Scorzoni, L, 2023) |
| " We herein report an HIV-infected patient with disseminated cryptococcosis involving multiple organs including the blood, brain, lungs, and bone marrow, who developed progressive pancytopenia after initiation of anti-fungal treatment with liposomal amphotericin-B (L-AMB) and flucytosine (5FC)." | 4.12 | Progressive Cytopenia Developing during Treatment of Cryptococcosis in a Patient with HIV Infection and Bone Marrow Cryptococcal Infection. ( Ando, N; Aoki, T; Katsura, M; Kikuchi, Y; Koizumi, Y; Mizushima, D; Oka, S; Okuhama, A; Teruya, K; Tsukada, K; Watanabe, K; Yanagawa, Y, 2022) |
| " Flucytosine (5FC) has shown synergistic effect with AmB for treatment of some fungal infections, such as cryptococcosis, but again, its price is a limitation for its use in many regions." | 3.96 | Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and ( Agreda-Mellon, D; de Oliveira, HC; García-Cambero, JP; Lucio, J; Mendes-Giannini, MJS; Rossi, SA; Zaragoza, O, 2020) |
| "The second cause of death among systemic mycoses, cryptococcosis treatment represents a challenge since that 5-flucytosine is not currently available in Brazil." | 3.83 | Evaluation of antifungal combination against Cryptococcus spp. ( Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H, 2016) |
| "The aims of this study are to make a more precise identification of the etiologic agent of a nasal granuloma in a cat, to verify the susceptibility to the antifungal drugs: ketoconazole, itraconazole, fluconazole, posaconazole, voriconazole, amphotericin B and the proper treatment." | 3.79 | Feline nasal granuloma due to Cryptoccocus gattii type VGII. ( Baroni, Fde A; Cardoso, PH; Martins, Mdos A; Nascimento, DC; Paula, CR; Silva, EG; Szezs, W, 2013) |
| " Staining with periodic acid-Schiff, Grocott's methenamine silver and Fontana-Masson revealed yeast-form fungus in the granulomas." | 3.74 | Granulomatous prostatitis due to Cryptococcus neoformans: diagnostic usefulness of special stains and molecular analysis of 18S rDNA. ( Murakami, C; Nakano, N; Wada, R; Wakasaya, Y; Yagihashi, S; Yajima, N; Yamato, K; Yoneyama, T, 2008) |
| " Thus, the efficacy of amphotericin B and flucytosine in combination was investigated by mortality and fungal burden studies in a murine model of disseminated cryptococcosis using two clinical isolates of Cryptococcus neoformans, one susceptible and one resistant (i." | 3.73 | Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. ( Dannaoui, E; Dromer, F; Lortholary, O; Schwarz, P, 2006) |
| "A patient with thoracic cryptococcal osteomyelitis was treated successfully with the combination of fluconazole and flucytosine." | 3.71 | Successful treatment of cryptococcal osteomyelitis and paraspinous abscess with fluconazole and flucytosine. ( Cook, PP, 2001) |
| "We report two cases of cryptococcosis in patients with Waldenstrom's macroglobulinaemia and chronic lymphocytic leukaemia that responded to prolonged therapy with systemic amphotericin and flucytosine." | 3.70 | Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders. ( Colbridge, M; Keenan, F; Melzer, M; Ong, EL; Stainsby, D, 1998) |
| " We report a patient with cryptococcal meningitis who, while on intravenous 5-flucytosine and amphotericin B, developed life-threatening bilateral massive pleural effusions with evidence of spontaneous resolution, consistent with prior hypothesis of antigenic stimulation as the cause of pleural involvement." | 3.70 | Massive pleural effusions in cryptococcal meningitis. ( Liam, CK; Lim, KH; Wong, CM, 1999) |
| "5 years of anti-mycotic chemotherapy with amphotericin B and flucytosine, pneumothorax occurred in the left lung." | 3.69 | [A case of primary pulmonary cryptococcosis associated with pneumothorax]. ( Kitamura, S; Saitoh, K; Shibuya, Y; Sohara, Y, 1995) |
| "Six cases (3 cats, 3 dogs) of cryptococcosis were cured using combination chemotherapy that included amphotericin B." | 3.69 | Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. ( Craig, AJ; Love, DN; Malik, R; Martin, P; Wigney, DI, 1996) |
| "7 of 8 dogs receiving combination drug therapy consisting of flucytosine together with amphotericin B and/or a triazole for cryptococcosis or aspergillosis developed cutaneous or mucocutaneous eruptions during the course of treatment." | 3.69 | Suspected drug eruption in seven dogs during administration of flucytosine. ( Love, DN; Malik, R; Medeiros, C; Wigney, DI, 1996) |
| "Three patients with AIDS in whom multifocal choroiditis and choroidal lesions were the initial signs of disseminated cryptococcosis were treated with systemic amphotericin B and flucytosine." | 3.69 | Presumed multifocal cryptococcol choroidopathy prior to specific systemic manifestation. ( Dugel, PU; Kolahdouz-Isfahani, A; Rao, NA; Rostomian, K; Smith, RE; Thach, AB, 1997) |
| "The efficacy of the combination therapy of fluconazole plus flucytosine against pulmonary cryptococcosis was investigated." | 3.68 | [Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine]. ( Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S; Mitsutake, K; Miyazaki, H; Miyazaki, T; Tanaka, K; Tomono, K, 1993) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "This is a case report of fatal cryptococcal meningitis in a child with systemic lupus erythematosus being treated with prednisolone and azathioprine." | 3.68 | Cryptococcal meningitis in a child with systemic lupus erythematosus. ( al-Fawaz, IM; al-Rasheed, SA, 1990) |
| " Cryptococcal meningitis is a common life-threatening infection in AIDS patients, usually treated with amphotericin B, often in combination with flucytosine." | 3.68 | Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. ( Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR, 1991) |
| "Experiments are described of the treatment of two patients with cryptococcal meningitis using antifungal drugs and amphotericin B." | 3.68 | Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B. ( Shindo, K, 1990) |
| "To assess the possible beneficial effects of combined therapy (fluconazole and flucytosine) in the treatment of cryptococcal meningitis in the immunocompromised host, we compared therapy with fluconazole and flucytosine, individually and combined, in the experimental murine model." | 3.68 | Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. ( Allendoerfer, R; Graybill, JR; Marquis, AJ; Rinaldi, MG, 1991) |
| " Under cover of miconazole and 5-fluorocytosine, pulmonary mass lesions were successfully removed despite the fact that the patients had meningitis." | 3.67 | Treatment of cryptococcal meningitis with pulmonary granuloma. ( Inoue, N; Murai, Y; Murakami, M; Ohishi, T; Uozumi, T; Yamamoto, T; Yoshimatsu, H, 1984) |
| " We examined four issues: the efficacy of treatment with amphotericin plus flucytosine as compared with amphotericin alone, the efficacy of suppressive therapy, the prognostic clinical characteristics, and the course of nonmeningeal cryptococcosis." | 3.67 | Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. ( Chuck, SL; Sande, MA, 1989) |
| "Combination pairs of 5-fluorocytosine (5-FC) + itraconazole (Itra), 5-FC + fluconazole (Fluc), and amphotericin B (Amph B) + Itra were administered to mice with experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis with a variety of combination ratios." | 3.67 | Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ( Polak, A, 1987) |
| " The pulmonary mass was removed under cover of miconazole and 5-fluorocytosine even though the patient had concomitant active meningitis." | 3.67 | Surgery in combined pulmonary and neural cryptococcosis. ( Araj, GF; Bezjak, V; Jadaa, SI; Sa'adah, MA; Shakir, RA, 1987) |
| " In renal transplant recipients receiving prednisone, the development of cryptococcosis is associated with a poor prognosis." | 3.67 | Cure of cryptococcal infection during continued immunosuppressive therapy. ( Braverman, R; Cabreja, RF; Russell, RP; Watson, AJ; Whelton, A, 1985) |
| "Ketoconazole, amphotericin B, 5-fluorocytosine, and combinations of these drugs were compared as therapy for chronic cryptococcal meningitis in steroid-treated rabbits." | 3.66 | Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. ( Durack, DT; Perfect, JR, 1982) |
| "Combination pairs of the major systematic antimycotic drugs, amphotericin B (AmphB), 5-fluorocytosine (5-FC) and ketoconazole (Ktz) were administered to mice with experimental candidiasis, cryptococcosis and aspergillosis at a variety of combination ratios." | 3.66 | Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. ( Polak, A; Scholer, HJ; Wall, M, 1982) |
| "The authors report a case of colitis, with anatomo-clinical confrontation, during a treatment with flucytosine." | 3.66 | [Iatrogenic colitis during flucytosine treatment for neuromeningeal cryptococcosis]. ( Bentata-Pessayre, M; Callard, P; Delzant, G; Dupont, B; Fond, B; Krivitzky, A, 1983) |
| "A 50-year-old woman with cryptococcal meningitis was treated with amphotericin B intrathecally through a Rickham reservoir and intravenously, together with flucytosine orally." | 3.66 | Cryptococcal meningitis: complications due to intrathecal treatment. ( Esmann, V; Schønheyder, H; Stenderup, A; Thestrup-Pedersen, K, 1980) |
| "Flucytosine-associated diarrhea has been previously described in 6%-10% of patients receiving the drug." | 3.66 | Ulcerating enteritis associated with flucytosine therapy. ( Traube, J; White, CA, 1982) |
| "A 3-year-old girl in poor general condition was admitted with a diagnosis of cryptococcosis and treated with 5-fluorocytosine." | 3.66 | Cryptococcosis with cutaneous manifestations treated with 5-fluorocytosine. ( Kim, HJ; Lee, S, 1980) |
| "Results obtained in the treatment of cryptococcosis of the central nervous system with amphotericin-B, 5-fluorocytosine and miconazole are evaluated." | 3.66 | [Cryptococcosis of the central nervous system: evaluation of amphotericin-B, 5-fluorocytosine and miconazole therapy in 18 cases]. ( Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A, 1979) |
| "Treatment with flucytosine of 20 patients with fungal infections gave favorable results in four patients with crytococcal infections, two of four patients with disseminated candidiasis, eight of ten patients with urinary tract infections due to Candida albicans and Torulopsis glabrata, and tow of three patients with miscellaneous infections due to Calbicans." | 3.65 | Treatment of fungal infections with flucytosine. ( Harder, EJ; Hermans, PE, 1975) |
| "In a prospective study from May 1971 to November 1973, 20 consecutive patients with a diagnosis of disseminated cryptococcosis were treated for six weeks with a combination of amphotericin B (20 mg daily) intravenously and flucytosine (150 mg/kg daily) orally." | 3.65 | Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. ( Duma, RJ; Garriques, IL; Mandell, GL; McGehee, RF; Sande, MA; Shadomy, S; Utz, JP; Warner, JF, 1975) |
| "Cryptococcosis is a fungal disease of public health relevance that affects numerous animal species and humans, causing respiratory and neurological impairment." | 3.01 | Cryptococcosis in domestic and wild animals: A review. ( Bermann, CDS; Botton, SA; Braga, CQ; Ianiski, LB; Pereira, DIB, 2023) |
| "In patients with the acquired immunodeficiency syndrome (AIDS), the rate of relapse after primary treatment for cryptococcal meningitis remains high." | 2.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| "Presentation with pleural effusion is rare in cryptococcal disease; in fact, only 4 cases of pleural effusion as the initial clinical presentation in cryptococcosis have been reported in English-language literature to date." | 2.52 | Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review. ( Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X, 2015) |
| " At a dosage of 400 mg per day, fluconazole alone is much less rapidly fungicidal than amphotericin B and is associated with the development of secondary resistance." | 2.44 | Managing cryptococcosis in the immunocompromised host. ( Dromer, F; Harrison, TS; Jarvis, JN; Lortholary, O, 2008) |
| "Hydrocephalus is the most common neurosurgical complication of cerebral cryptococcosis." | 2.38 | [Neurological form of cryptococcosis. Apropos of 2 atypical cases in non HIV-infected patients]. ( Donnet, A; Durand, JM; Graziani, N; Grisoli, F; Harlé, JR; Touta, A, 1993) |
| "Cryptococcosis is currently the most common life threatening mycoses found in patients with the acquired immunodeficiency syndrome (AIDS)." | 2.38 | Overview: cryptococcosis in the patient with AIDS. ( Sugar, AM, 1991) |
| "Cryptococcosis is the most common life-threatening mycosis with AIDS." | 2.38 | [Cryptococcosis in AIDS: therapeutic concepts]. ( Ruf, B, 1990) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| "Flucytosine is a systemic antifungal drug that is readily absorbed from the gastrointestinal tract." | 2.36 | Flucytosine. ( Bennet, JE, 1977) |
| "Flucytosine-based treatment can be delivered in routine care in a middle-income country with a substantial survival benefit." | 1.72 | Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study. ( Black, J; Boretti, L; Garcia, A; Govender, NP; Greene, GS; Harrison, TS; Madua, M; Mashau, RC; Meintjes, G; Meiring, ST; Menezes, C; Nel, J; Quan, VC; Reddy, DL; Shroufi, A; Stacey, S; Trivino-Duran, L; Venter, M, 2022) |
| "Treatment with fluconazole is only recommended for localised pulmonary disease." | 1.62 | Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease. ( Larson, L; Mejia-Chew, C; Powderly, WG; Spec, A; Sung, A, 2021) |
| "Cutaneous cryptococcosis is classified as localized cutaneous cryptococcosis and cutaneous manifestations of disseminated cryptococcosis." | 1.56 | Disseminated cutaneous cryptococcosis in an immunocompetent elderly long-term pigeon fancier. ( Abe, M; Anzawa, K; Futatsuya, T; Hoshino, Y; Mochizuki, T; Shoji, A, 2020) |
| "Cryptococcosis is a fungal infection of the central nervous system predominantly caused by Cryptococcus neoformans in immunocompromised patients." | 1.51 | Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017. ( Becker, SL; Fuchs, V; Gerkrath, J; Graf, B; Hamprecht, A; Han, CO; Heckmann, D; Held, J; Hogardt, M; Idelevich, EA; Küpper-Tetzel, CP; McCormick-Smith, I; Rickerts, V; Schwarz, R; Sedlacek, L; Selb, R; Wilmes, D, 2019) |
| "The present study showed that mixed infections exist and could be of particular importance for care outcomes." | 1.51 | Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study. ( Bellet, V; Bertout, S; Chabrol, A; Delaporte, E; Doumbia, A; Drakulovski, P; Kakou, A; Kassi, FK; Krasteva, D; Landman, R; Menan, HEI; Reynes, J; Roger, F, 2019) |
| "Cryptococcal prostatitis is a rare clinical disease and has never been reported in China." | 1.51 | An AIDS patient with urine retention. ( Cheng, J; Tao, R; Xu, L; Zhao, Q; Zhu, B, 2019) |
| "Cryptococcosis is an opportunistic fungal infection caused by members of the two sibling species complexes: Cryptococcus neoformans and Cryptococcus gattii." | 1.48 | Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway. ( Dreibe, EM; Engelthaler, DM; Gelli, A; Lockhart, SR; Meyer, W; Roe, CC; Sykes, JE; Thompson, GR; Vu, K, 2018) |
| "The fluconazole treatment was changed to liposomal amphotericin-B and flucytosine after the diagnosis of cryptococcal meningitis." | 1.40 | Pulmonary cryptococcosis with endobronchial lesions and meningitis. ( Ishiguro, T; Odashima, K; Shimizu, Y; Sugita, Y; Takayanagi, N, 2014) |
| "Flucytosine exposure was associated with a lower overall mortality rate (HR, 0." | 1.39 | Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis. ( Bratton, EW; Chastain, CA; El Husseini, N; Juliano, JJ; Lee, MS; Perfect, JR; Poole, C; Stürmer, T; Weber, DJ, 2013) |
| "Cryptococcal osteomyelitis is extremely rare and almost always occurs in immunocompromised patients." | 1.38 | Cryptococcal osteomyelitis of the scapula and rib in an immunocompetent patient. ( Tang, ZH; Yu, YS; Zang, GQ; Zhang, Y, 2012) |
| "Treatment with amphotericin B(AMPH-B) and flucytosine(5-FC) was initiated as diagnosis of cryptococcus meningitis." | 1.37 | Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review. ( Ainoda, Y; Fujita, T; Hirai, Y; Mori, N; Motoji, T; Shiseki, M; Shoji, T; Teramura, M; Totsuka, K; Yoshinaga, K, 2011) |
| "The eosinophilia was successfully alleviated by treatment for cryptococcal meningitis." | 1.35 | Disseminated cryptococcal infection with eosinophilia in a healthy person. ( Ikehara, M; Komase, Y; Shinagawa, T; Yamaguchi, H; Yamamoto, T, 2008) |
| "Cryptococcosis is a life-threatening opportunistic fungal infection in both HIV-positive and -negative patients." | 1.34 | Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. ( Dromer, F; Launay, O; Lortholary, O; Mathoulin-Pélissier, S, 2007) |
| "Disseminated cryptococcosis is a rare and often fatal disease in children." | 1.33 | Disseminated infection with Cryptococcus neoformans var neoformans in an 8 years immunocompetent girl. ( Anand, VK; Chaudhary, MW; Dewan, V; Kumar, P; Sardana, K, 2005) |
| "Cryptococcosis is the third most common deep fungal infection in China and has not yet been reported to be associated with HIV infection there." | 1.33 | Management of cryptococcosis in non-HIV-related patients. ( Chen, R; Liao, W; Yao, Z, 2005) |
| " Clinical improvement was apparent for 13 months during steroid therapy until the slow taper reached a dosage of 20 mg/day." | 1.31 | Cryptococcal infection in sarcoidosis. ( Gibson, LE; Kist, JM; Mehrany, K, 2002) |
| "Few human cases of cryptococcosis have been reported over the last 50 years in Turkey." | 1.31 | A flucytosine-resistant Cryptococcus neoformans (serotype D) strain isolated in turkey from cutaneous lesions. ( Kantarcioglu, AS; Yücel, A, 2002) |
| "The isolates were from AIDS patients who had either died or had failed to show a clinical response during amphotericin B (AMB) treatment." | 1.31 | In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy. ( Cahn, P; Canteros, C; Córdoba, S; Davel, G; Guelfand, L; Hochenfellner, F; Kaufman, S; Rodero, L, 2000) |
| " Following treatment, she developed a reversible acute cerebellar syndrome that was probably secondary to the administration of flucytosine, an adverse effect that has not previously been described [3, 4]." | 1.30 | Acute cerebellopathy as a probable toxic effect of flucytosine. ( Barquero Jimenez, S; Cubo Delgado, E; Garcia Urra, D; Sanz Boza, R; Vargas Castrillon, E, 1997) |
| " Fluconazole, at a dosage equivalent to 800 mg/day administered orally, and flucytosine, also given orally, led to a clinical response and a steady decline in serum cryptococcal antigen titer, which became negative at 6 weeks of therapy." | 1.30 | Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen. ( Gayowski, T; Marino, IR; Singh, N, 1998) |
| "laurentii meningitis was controlled after 2 weeks of treatment with no evidence of infection 20 months later." | 1.30 | First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. ( Avlami, A; Georgakopoulos, G; Kordossis, T; Legakis, NJ; Papalambrou, C; Stefanou, I; Velegraki, A, 1998) |
| "Treatment with amphotericin B (1000 mg total dose) and oral 5-fluorocytosine, resulted in complete recovery and resolution of the chest X-ray findings with a follow-up of 2 years." | 1.29 | Cryptococcus neoformans vertebral osteomyelitis. ( Block, C; Farfel, Z; Goldschmied-Reuven, A; Gurevitz, O; Hassin, D; Kopolovic, J, 1994) |
| "The patient died from the Cryptococcus infection on day 74 of the antimycotic therapy." | 1.29 | [Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency]. ( Blaschke-Hellmessen, R; Kabus, M; Kaulen, F; Schwarze, R; Wendisch, J, 1996) |
| "Cryptococcosis is more frequently observed since the appearance of the acquired immunodeficiency syndrome (AIDS)." | 1.28 | [Cryptococcosis: presentation of 26 cases]. ( Azón, A; Gatell, JM; González-Clemente, JM; Mallolas, J; Mensa, J; Miró, JM; Moreno, A; Pedrol, E; Soriano, E, 1992) |
| "Fluconazole has shown effectiveness in maintenance therapy, being not be possible to evaluate it as an acute phase therapy because the low number of cases in which it was studied." | 1.28 | [Cryptococcosis in AIDS patients: a study of 19 cases]. ( Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J, 1992) |
| "Cryptococcosis is a systemic fungal disease and meningeal or meningoencephalitis involvement is the most serious complication." | 1.28 | [Cryptococcosis in Bujumbura, Burundi. Apropos of 80 observed cases in 42 months]. ( Deppner, M; Dupont, B; Floch, JJ; Goasguen, J; Kadende, P; Laroche, R; Saunière, JF, 1990) |
| "Because the population of AIDS patients is increasing, physicians will be faced more often with the management of systemic fungal infections." | 1.28 | Treating systemic fungal infections in AIDS patients. Prolonging life against the odds. ( Scheld, WM, 1990) |
| "Two patients with acquired immune deficiency syndrome presented with headaches and fevers." | 1.28 | Cryptococcal choroiditis. ( Carney, MD; Combs, JL; Waschler, W, 1990) |
| " Long term administration of amphotericin B (cumulative dose 5 g) combined with 5-flucytosine eradicated this fungal infection." | 1.28 | [A case of systemic lupus erythematosus associated with cryptococcal meningitis which was successfully cured by the administration of massive dose of amphotericin B]. ( Chida, Y; Hiruma, M; Ida, T; Makiguchi, K; Malumo, F; Matsuda, O; Tsutsui, H, 1990) |
| "Treatment with amphotericin B and flucytosine was very effective, there being no more growth of fungi in cultures in most cases." | 1.28 | Cryptococcosis in AIDS patients: observations concerning CNS involvement. ( de Matos-Marques, B; Pohle, HD; Rögler, G; Seibold, M; Sixt, C; Staib, F; Weinke, T, 1989) |
| "Ketoconazole has been shown to penetrate into brain tissue of mice and cerebrospinal fluid of humans and to improve the course of human coccidioidal meningitis." | 1.27 | Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis. ( Craven, PC; Graybill, JR, 1984) |
| "BAY N 7133 was also effective for mouse candidosis by parenteral administration and was effective for guinea pig trichophytosis on topical application." | 1.27 | Antimycotic activity of BAY N 7133 in animal experiments. ( Plempel, M, 1984) |
| " Cryptococcemia was strongly associated with corticosteroid therapy, especially when the dosage had recently been increased." | 1.27 | Cryptococcemia. ( Durack, DT; Gallis, HA; Perfect, JR, 1983) |
| "The drugs used in the treatment of CNS cryptococcosis were, as possible, the amphotericin B by intravenous and intrathecal route (lumbar puncture) associated with 5-fluorocytosine." | 1.27 | [Amphotericin B in the treatment of neurocryptococcosis in patients subjected to renal transplantation]. ( Nóbrega, JP, 1988) |
| "In two AIDS patients (homosexual men) microscopical demonstration of Cryptococcus neoformans in samples obtained by puncture of the liver (n = 1) and additionally of the spleen (n = 1) led to the diagnosis of systemic cryptococcosis." | 1.27 | [Disseminated cryptococcosis in 2 AIDS patients. A contribution to cryptococcosis diagnosis in AIDS]. ( Eichenlaub, D; Pohle, HD; Prüfer-Krämer, L; Rögler, G; Seibold, M; Staib, F, 1986) |
| "Cryptococcosis was the initial manifestation of the syndrome in 7 patients, and the initial opportunistic infection in an additional 7." | 1.27 | Cryptococcosis in the acquired immunodeficiency syndrome. ( Gelmann, EP; Gill, VJ; Kovacs, AA; Kovacs, JA; Lane, HC; Longfield, R; Overturf, G; Polis, M; Tuazon, CU; Wright, WC, 1985) |
| "The risk for AIDS patients from Cryptococcus neoformans is outlined on the basis of a case report on a 28-year old male patient whose disease was complicated by cryptococcosis." | 1.27 | [Cryptococcus neoformans meningoencephalitis in AIDS]. ( Bohle, C; Sinn, M; Staib, F; Werner, E, 1986) |
| "Cryptococcal meningitis is a life-threatening disease." | 1.27 | [Cryptococcal meningitis]. ( Biniek, R; Hilgenstock, F; Schuchardt, V, 1986) |
| "Skeletal cryptococcosis is an uncommon infection." | 1.27 | Spastic paraparesis due to cryptococcal osteomyelitis. A case report. ( Matsushita, T; Suzuki, K, 1985) |
| "Cryptococcosis is a systemic fungal disease and meningitis is the most serious complication." | 1.27 | Cryptococcal meningitis. ( Tan, CB; Tjia, TL; Yeow, YK, 1985) |
| "Treatment with amphotericin B and 5-fluorocytosine failed to restore hearing." | 1.27 | Cryptococcal meningitis: presentation as sudden deafness. ( Flood, LM; Graham, MD; Maslan, MJ, 1985) |
| "Amphotericin B was administered in the first trimester in one case, and amphotericin B and flucytosine (5-fluorocytosine) were administered in the second trimester in the second." | 1.26 | Cryptococcal meningitis in pregnancy. ( Curole, DN, 1981) |
| " High-dose T-cin controls survived despite having received a cumulative dosage of more than twice the reported (LD(50)) mean lethal dose value." | 1.26 | Comparative study of trichothecin, amphotericin B, and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo. ( Hariri, A; Larsh, HW; Sneller, MR; Sorenson, WG, 1977) |
| "Human cryptococcosis is an exogenous human infection of increasing frequency and growing importance." | 1.26 | Cryptococcosis: a diagnostic challenge. ( Seeliger, HP, 1977) |
| " A reduction in the dosage of the 5-fluorocytosine resulted in a marked decrease in the excretion of urinary gravel which was shown to be a coprecipitate of 5-fluorocytosine and uric acid." | 1.26 | Crystalluria during flucytosine therapy. ( Chinwah, PM; Cobcroft, R; Williams, KM, 1979) |
| "Ten cases of cryptococcosis have been identified in a 13 year experience with more than 650 renal transplants." | 1.26 | Cryptococcosis after renal transplantation: report of ten cases. ( Husberg, BS; Schröter, GP; Starzl, TE; Temple, DR; Weil, R, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 190 (51.63) | 18.7374 |
| 1990's | 73 (19.84) | 18.2507 |
| 2000's | 41 (11.14) | 29.6817 |
| 2010's | 42 (11.41) | 24.3611 |
| 2020's | 22 (5.98) | 2.80 |
| Authors | Studies |
|---|---|
| Illnait-Zaragozi, MT | 1 |
| Martínez, GF | 1 |
| Curfs-Breuker, I | 1 |
| Fernández, CM | 1 |
| Boekhout, T | 2 |
| Meis, JF | 1 |
| Yang, F | 1 |
| Gritsenko, V | 1 |
| Lu, H | 1 |
| Zhen, C | 1 |
| Gao, L | 1 |
| Berman, J | 1 |
| Jiang, YY | 1 |
| Bellet, V | 3 |
| Roger, F | 3 |
| Krasteva, D | 3 |
| Gouveia, T | 1 |
| Drakulovski, P | 3 |
| Pottier, C | 1 |
| Bertout, S | 3 |
| Tucker, M | 1 |
| Sheikh, AM | 1 |
| Villanueva, MS | 1 |
| Mashau, RC | 1 |
| Meiring, ST | 1 |
| Quan, VC | 1 |
| Nel, J | 1 |
| Greene, GS | 1 |
| Garcia, A | 1 |
| Menezes, C | 1 |
| Reddy, DL | 1 |
| Venter, M | 1 |
| Stacey, S | 1 |
| Madua, M | 1 |
| Boretti, L | 1 |
| Harrison, TS | 3 |
| Meintjes, G | 1 |
| Shroufi, A | 1 |
| Trivino-Duran, L | 1 |
| Black, J | 1 |
| Govender, NP | 1 |
| Lin, KH | 1 |
| Lai, YC | 1 |
| Lin, YP | 1 |
| Ho, MW | 1 |
| Chen, YC | 2 |
| Chung, WH | 1 |
| Li, C | 1 |
| Zhen, S | 1 |
| Ma, X | 2 |
| Ma, L | 1 |
| Wang, Z | 1 |
| Zhang, P | 1 |
| Zhu, X | 1 |
| Qurashi, S | 1 |
| Saleem, T | 1 |
| Kovalenko, I | 1 |
| Golubykh, K | 1 |
| Holleran, L | 1 |
| Yang, DH | 1 |
| Khanal Lamichhane, A | 2 |
| Kwon-Chung, KJ | 2 |
| Chang, YC | 2 |
| Bermann, CDS | 1 |
| Braga, CQ | 1 |
| Ianiski, LB | 1 |
| Botton, SA | 1 |
| Pereira, DIB | 1 |
| Sousa, NSO | 1 |
| Almeida, JDR | 1 |
| Frickmann, H | 1 |
| Lacerda, MVG | 1 |
| Souza, JVB | 1 |
| Bive, BZ | 1 |
| Sacheli, R | 1 |
| Mudogo, CN | 1 |
| Zakayi, PK | 1 |
| Bontems, S | 1 |
| Lelo, GM | 1 |
| Hayette, MP | 1 |
| Munzen, ME | 1 |
| Reguera Gomez, M | 1 |
| Hamed, MF | 1 |
| Enriquez, V | 1 |
| Charles-Niño, CL | 1 |
| Dores, MR | 1 |
| Alviña, K | 1 |
| Martinez, LR | 1 |
| Pereira, TC | 1 |
| do Carmo, PHF | 1 |
| de Menezes, RT | 1 |
| de Oliveira, HC | 2 |
| de Oliveira, LD | 1 |
| Junqueira, JC | 1 |
| Scorzoni, L | 1 |
| Selb, R | 1 |
| Fuchs, V | 1 |
| Graf, B | 1 |
| Hamprecht, A | 1 |
| Hogardt, M | 1 |
| Sedlacek, L | 1 |
| Schwarz, R | 1 |
| Idelevich, EA | 1 |
| Becker, SL | 1 |
| Held, J | 1 |
| Küpper-Tetzel, CP | 1 |
| McCormick-Smith, I | 1 |
| Heckmann, D | 1 |
| Gerkrath, J | 1 |
| Han, CO | 1 |
| Wilmes, D | 1 |
| Rickerts, V | 1 |
| Garraffo, HM | 1 |
| Cai, H | 1 |
| Walter, PJ | 1 |
| Kassi, FK | 2 |
| Chabrol, A | 1 |
| Doumbia, A | 2 |
| Landman, R | 1 |
| Kakou, A | 1 |
| Reynes, J | 2 |
| Delaporte, E | 2 |
| Menan, HEI | 1 |
| Xu, L | 1 |
| Tao, R | 1 |
| Zhao, Q | 1 |
| Cheng, J | 1 |
| Zhu, B | 1 |
| Rossi, SA | 1 |
| Agreda-Mellon, D | 1 |
| Lucio, J | 1 |
| Mendes-Giannini, MJS | 1 |
| García-Cambero, JP | 1 |
| Zaragoza, O | 1 |
| Futatsuya, T | 1 |
| Anzawa, K | 1 |
| Mochizuki, T | 1 |
| Shoji, A | 1 |
| Hoshino, Y | 1 |
| Abe, M | 1 |
| Fujimoto, S | 1 |
| Oda, N | 1 |
| Fujioka, Y | 1 |
| Mitani, R | 1 |
| Takata, I | 1 |
| Mejia-Chew, C | 1 |
| Sung, A | 1 |
| Larson, L | 1 |
| Powderly, WG | 3 |
| Spec, A | 1 |
| Xue, X | 1 |
| Deng, H | 1 |
| Zhao, L | 1 |
| Zang, X | 1 |
| Asuquo, IP | 1 |
| Meng, M | 1 |
| Qin, C | 1 |
| Meng, Y | 1 |
| Wu, C | 1 |
| Gao, J | 1 |
| Pan, L | 1 |
| Yu, H | 1 |
| Wang, K | 1 |
| Huang, D | 2 |
| Wen, L | 1 |
| Zhang, Y | 2 |
| Wang, Y | 1 |
| Tang, Y | 1 |
| Dong, J | 1 |
| Liang, Z | 1 |
| Stott, KE | 1 |
| Loyse, A | 1 |
| Jarvis, JN | 2 |
| Alufandika, M | 1 |
| Mwandumba, HC | 1 |
| Day, JN | 1 |
| Lalloo, DG | 1 |
| Bicanic, T | 1 |
| Perfect, JR | 5 |
| Hope, W | 1 |
| Cho, YJ | 1 |
| Han, SI | 1 |
| Lim, SC | 1 |
| Katsura, M | 1 |
| Okuhama, A | 1 |
| Koizumi, Y | 1 |
| Ando, N | 1 |
| Yanagawa, Y | 1 |
| Mizushima, D | 1 |
| Aoki, T | 1 |
| Tsukada, K | 1 |
| Teruya, K | 1 |
| Kikuchi, Y | 1 |
| Oka, S | 1 |
| Watanabe, K | 1 |
| Poenaru, SM | 1 |
| Rofaiel, R | 1 |
| Hosseini-Moghaddam, SM | 1 |
| Valérie, BA | 1 |
| Aboubakar, T | 1 |
| Kouakou, GA | 1 |
| Yavo, W | 1 |
| Menan, HIE | 1 |
| Vu, K | 1 |
| Thompson, GR | 1 |
| Roe, CC | 1 |
| Sykes, JE | 1 |
| Dreibe, EM | 1 |
| Lockhart, SR | 1 |
| Meyer, W | 2 |
| Engelthaler, DM | 1 |
| Gelli, A | 1 |
| Johnson, WJ | 1 |
| Blice, JP | 1 |
| Lee, KK | 1 |
| Nishikawa, MM | 1 |
| Almeida-Paes, R | 1 |
| Brito-Santos, F | 1 |
| Nascimento, CR | 1 |
| Fialho, MM | 1 |
| Trilles, L | 1 |
| Morales, BP | 1 |
| da Silva, SA | 1 |
| Santos, W | 1 |
| Santos, LO | 1 |
| Fortes, ST | 1 |
| Cardarelli-Leite, P | 1 |
| Lázera, MDS | 1 |
| Rossato, L | 1 |
| Loreto, ES | 1 |
| Venturini, TP | 1 |
| de Azevedo, MI | 1 |
| Al-Hatmi, AMS | 1 |
| Santurio, JM | 1 |
| Alves, SH | 1 |
| Jandhyala, D | 1 |
| Tan, EM | 1 |
| Stahr, DC | 1 |
| Sohail, MR | 1 |
| Bratton, EW | 1 |
| El Husseini, N | 1 |
| Chastain, CA | 1 |
| Lee, MS | 1 |
| Poole, C | 1 |
| Stürmer, T | 1 |
| Weber, DJ | 1 |
| Juliano, JJ | 1 |
| Trpković, A | 1 |
| Pekmezović, M | 1 |
| Barać, A | 1 |
| Crnčević Radović, L | 1 |
| Arsić Arsenijević, V | 1 |
| Chen, SC | 1 |
| Korman, TM | 1 |
| Slavin, MA | 1 |
| Marriott, D | 1 |
| Byth, K | 1 |
| Bak, N | 1 |
| Currie, BJ | 1 |
| Hajkowicz, K | 1 |
| Heath, CH | 1 |
| Kidd, S | 1 |
| McBride, WJ | 1 |
| Murray, R | 1 |
| Playford, EG | 1 |
| Sorrell, TC | 2 |
| Cardoso, PH | 1 |
| Baroni, Fde A | 1 |
| Silva, EG | 1 |
| Nascimento, DC | 1 |
| Martins, Mdos A | 1 |
| Szezs, W | 1 |
| Paula, CR | 1 |
| Wang, J | 1 |
| Ju, HZ | 1 |
| Yang, MF | 1 |
| Banerjee, D | 1 |
| Burkard, L | 1 |
| Panepinto, JC | 1 |
| Gariani, K | 1 |
| Rougemont, M | 1 |
| Renzi, G | 1 |
| Hibbs, J | 1 |
| Emonet, S | 1 |
| Schrenzel, J | 1 |
| Wen, Y | 1 |
| Deng, S | 1 |
| Zhu, Y | 1 |
| Wan, C | 1 |
| Molter, CM | 1 |
| Zuba, JR | 1 |
| Papendick, R | 1 |
| Debenedectis, CM | 1 |
| McCulloh, RJ | 1 |
| Healey, TT | 1 |
| Mahabeer, Y | 1 |
| Chang, CC | 1 |
| Naidu, D | 1 |
| Dorasamy, A | 1 |
| Lewin, S | 1 |
| Ndung'u, T | 1 |
| Moosa, MY | 1 |
| French, M | 1 |
| Mlisana, K | 1 |
| Coovadia, Y | 1 |
| Espino Barros Palau, A | 1 |
| Morgan, ML | 1 |
| Foroozan, R | 1 |
| Lee, AG | 1 |
| Odashima, K | 1 |
| Takayanagi, N | 1 |
| Ishiguro, T | 1 |
| Shimizu, Y | 1 |
| Sugita, Y | 1 |
| Desnos-Ollivier, M | 1 |
| Patel, S | 1 |
| Raoux-Barbot, D | 1 |
| Heitman, J | 2 |
| Dromer, F | 7 |
| Chen, M | 1 |
| Wang, X | 1 |
| Yu, X | 1 |
| Dai, C | 1 |
| Chen, D | 1 |
| Yu, C | 1 |
| Xu, X | 1 |
| Yao, D | 1 |
| Yang, L | 1 |
| Li, Y | 1 |
| Wang, L | 1 |
| Huang, X | 1 |
| Córdoba, S | 2 |
| Isla, MG | 1 |
| Szusz, W | 1 |
| Vivot, W | 1 |
| Altamirano, R | 1 |
| Davel, G | 2 |
| Reichert-Lima, F | 1 |
| Busso-Lopes, AF | 1 |
| Lyra, L | 1 |
| Peron, IH | 1 |
| Taguchi, H | 1 |
| Mikami, Y | 1 |
| Kamei, K | 1 |
| Moretti, ML | 1 |
| Schreiber, AZ | 1 |
| Zhu, TH | 1 |
| Rodriguez, PG | 1 |
| Behan, JW | 1 |
| Declerck, B | 1 |
| Kim, GH | 1 |
| Tsuji, G | 1 |
| Matsuda, T | 2 |
| Shigyo, A | 1 |
| Furue, M | 1 |
| Rezai, MS | 1 |
| Khotael, G | 1 |
| Kheirkhah, M | 1 |
| Hedayat, T | 1 |
| Geramishoar, M | 1 |
| Mahjoub, F | 1 |
| Bernede-Bauduin, C | 1 |
| Guillemot, D | 1 |
| Lortholary, O | 6 |
| Yamaguchi, H | 1 |
| Komase, Y | 1 |
| Ikehara, M | 1 |
| Yamamoto, T | 2 |
| Shinagawa, T | 1 |
| Wu, B | 1 |
| Liu, H | 1 |
| Huang, J | 1 |
| Zhang, W | 1 |
| Zhang, T | 1 |
| Lu, S | 1 |
| Furth, EE | 1 |
| Blumberg, EA | 1 |
| Bing, Z | 1 |
| Georgi, A | 1 |
| Schneemann, M | 1 |
| Tintelnot, K | 1 |
| Calligaris-Maibach, RC | 1 |
| Meyer, S | 1 |
| Weber, R | 1 |
| Bosshard, PP | 1 |
| Wykoff, CC | 1 |
| Albini, TA | 1 |
| Couvillion, SS | 1 |
| Dubovy, SR | 1 |
| Davis, JL | 1 |
| Patel, NC | 1 |
| Ewanowski, C | 1 |
| Kupiec-Banasikowska, A | 1 |
| Hogan, KP | 1 |
| Liggett, J | 1 |
| Ozog, D | 1 |
| Marie, I | 1 |
| Cheriet, S | 1 |
| Assie, C | 1 |
| Etienne, M | 1 |
| Favennec, L | 1 |
| Hirai, Y | 1 |
| Ainoda, Y | 1 |
| Shoji, T | 1 |
| Fujita, T | 1 |
| Yoshinaga, K | 1 |
| Shiseki, M | 1 |
| Mori, N | 1 |
| Teramura, M | 1 |
| Totsuka, K | 1 |
| Motoji, T | 1 |
| Garrett, L | 1 |
| Marr, K | 1 |
| West, S | 1 |
| Allada, G | 1 |
| García-Lázaro, M | 1 |
| Salido, R | 1 |
| Arenas, C | 1 |
| Rivero, A | 1 |
| Song, MH | 1 |
| Lee, JW | 1 |
| Kim, MS | 1 |
| Yoon, JK | 1 |
| White, TC | 1 |
| Floyd, A | 1 |
| Strain, AK | 1 |
| Nielsen, JN | 1 |
| Nielsen, K | 1 |
| Bahn, YS | 1 |
| Yu, YS | 1 |
| Tang, ZH | 1 |
| Zang, GQ | 1 |
| Kresch, ZA | 1 |
| Espinosa-Heidmann, D | 1 |
| Harper, T | 1 |
| Jamie Miller, G | 1 |
| Nankeu, S | 1 |
| Djaha, JM | 1 |
| Saint Marcoux, B | 1 |
| Kaci, R | 1 |
| Debandt, M | 1 |
| Munson, E | 1 |
| Olson, R | 1 |
| Maliner, LI | 1 |
| Paterson, DL | 1 |
| Singh, N | 2 |
| Mehrany, K | 1 |
| Kist, JM | 1 |
| Gibson, LE | 1 |
| Kantarcioglu, AS | 2 |
| Yücel, A | 2 |
| Farina, C | 1 |
| Arosio, M | 1 |
| Moioli, F | 1 |
| Vailati, F | 1 |
| Goglio, A | 1 |
| Vilchez, R | 1 |
| Shapiro, R | 1 |
| McCurry, K | 1 |
| Kormos, R | 1 |
| Abu-Elmagd, K | 1 |
| Fung, J | 1 |
| Kusne, S | 1 |
| Viviani, MA | 2 |
| Esposto, MC | 1 |
| Cogliati, M | 1 |
| Tortorano, AM | 2 |
| GRUNBERG, E | 1 |
| TITSWORTH, E | 1 |
| BENNETT, M | 1 |
| Suranyi, E | 1 |
| Maroon, M | 1 |
| Tyler, WB | 1 |
| Zhu, LP | 1 |
| Gil-Lamaignere, C | 1 |
| Müller, FM | 1 |
| Fine, HF | 1 |
| Chang, MA | 1 |
| Dunn, JP | 1 |
| Chaudhary, MW | 1 |
| Sardana, K | 1 |
| Kumar, P | 1 |
| Dewan, V | 1 |
| Anand, VK | 1 |
| Yao, Z | 1 |
| Liao, W | 1 |
| Chen, R | 1 |
| Schwarz, P | 1 |
| Dannaoui, E | 2 |
| Abdul, M | 1 |
| Arpin, M | 1 |
| Michel-Nguyen, A | 1 |
| Piens, MA | 1 |
| Favel, A | 1 |
| de Souza, JA | 1 |
| Danko, JR | 1 |
| Roberts, A | 1 |
| Law, JK | 1 |
| Amar, JN | 1 |
| Kirby, SD | 1 |
| Zetler, PJ | 1 |
| Enns, RA | 1 |
| Mathoulin-Pélissier, S | 1 |
| Launay, O | 1 |
| De Hoog, GS | 1 |
| Theelen, B | 1 |
| Ekmekci, TR | 1 |
| Fries, BC | 1 |
| Ikeda, R | 1 |
| Koslu, A | 1 |
| Altas, K | 1 |
| Wada, R | 1 |
| Nakano, N | 1 |
| Yajima, N | 1 |
| Yoneyama, T | 1 |
| Wakasaya, Y | 1 |
| Murakami, C | 1 |
| Yamato, K | 1 |
| Yagihashi, S | 1 |
| Johnson, RE | 1 |
| Campbell-Bright, S | 1 |
| Raasch, RH | 1 |
| Rodgers, JE | 1 |
| Rosenberg, BS | 1 |
| Langberg, CW | 1 |
| Barkve, H | 1 |
| Tjørstad, K | 1 |
| Hino, H | 1 |
| Takizawa, K | 1 |
| Asboe-Hansen, G | 1 |
| Durack, DT | 2 |
| Polak, A | 4 |
| Scholer, HJ | 2 |
| Wall, M | 1 |
| Stamm, AM | 3 |
| Dismukes, WE | 6 |
| Fond, B | 1 |
| Bentata-Pessayre, M | 1 |
| Krivitzky, A | 1 |
| Callard, P | 1 |
| Dupont, B | 3 |
| Delzant, G | 1 |
| Craven, PC | 3 |
| Graybill, JR | 5 |
| Plempel, M | 2 |
| Gallis, HA | 3 |
| Hermans, PE | 4 |
| Keys, TF | 1 |
| Clemente González, C | 1 |
| Jacobs, DH | 1 |
| Macher, AM | 1 |
| Handler, R | 1 |
| Bennett, JE | 5 |
| Collen, MJ | 1 |
| Gallin, JI | 1 |
| Catanzaro, A | 1 |
| Inoue, N | 1 |
| Uozumi, T | 1 |
| Ohishi, T | 1 |
| Murai, Y | 1 |
| Murakami, M | 1 |
| Yoshimatsu, H | 1 |
| Odegaard, A | 1 |
| Steinbakk, M | 1 |
| Stavem, P | 1 |
| Schønheyder, H | 3 |
| Thestrup-Pedersen, K | 3 |
| Esmann, V | 3 |
| Stenderup, A | 3 |
| van Dellen, JR | 1 |
| Buchanan, N | 1 |
| Chapman-Smith, JS | 1 |
| Parr, DH | 1 |
| Say, PJ | 1 |
| Allen, R | 1 |
| Barter, CE | 1 |
| Chachoua, LL | 1 |
| Cleeve, L | 1 |
| O'Connell, JM | 1 |
| Daniel, FJ | 1 |
| Bayer, AS | 1 |
| Choi, C | 1 |
| Tillman, DB | 1 |
| Guze, LB | 1 |
| Da Silva, JA | 1 |
| Chaves, E | 1 |
| Da Silva, EB | 1 |
| Muther, RS | 1 |
| Bennett, WM | 1 |
| Thianprasit, M | 1 |
| De Wytt, CN | 1 |
| Dickson, PL | 1 |
| Holt, GW | 1 |
| Seebacher, C | 1 |
| Blaschke-Hellmessen, R | 3 |
| Sachs, B | 1 |
| Hermann, V | 1 |
| Morgner, J | 1 |
| Hammerschlag, MR | 1 |
| Domingo, J | 1 |
| Haller, JO | 1 |
| Papayanopulos, D | 1 |
| Steckel, RR | 1 |
| Adams, SB | 1 |
| Long, GG | 1 |
| Rebar, AH | 1 |
| White, CA | 1 |
| Traube, J | 1 |
| Bayardelle, P | 1 |
| Giard, N | 1 |
| Maltais, R | 1 |
| Delorme, J | 1 |
| Brazeau, M | 1 |
| Moore, R | 1 |
| Tokumaru, Y | 1 |
| Kojima, S | 1 |
| Yamada, T | 1 |
| Ito, N | 1 |
| Hirayama, K | 1 |
| Hay, RJ | 3 |
| Mackenzie, DW | 1 |
| Campbell, CK | 1 |
| Philpot, CM | 1 |
| Weis, RF | 1 |
| Everett, ED | 1 |
| Sprouse, R | 1 |
| Elfervig, JL | 1 |
| Curole, DN | 1 |
| Laggner, A | 1 |
| Pointner, H | 1 |
| Deutsch, E | 1 |
| Schnaberth, G | 1 |
| Maida, E | 1 |
| Perrier, F | 1 |
| Mehl, M | 1 |
| Fujita, N | 1 |
| Grinnell, V | 1 |
| Edwards, JE | 1 |
| Feldman, RA | 1 |
| Falconer, H | 2 |
| Terry, SI | 2 |
| Spencer, H | 1 |
| Cross, JN | 1 |
| King, SD | 1 |
| Chen, W | 1 |
| Sparke, B | 1 |
| Chu, AC | 1 |
| MacDonald, DM | 1 |
| Lee, S | 1 |
| Kim, HJ | 1 |
| Schmidt-Westhausen, A | 1 |
| Grünewald, T | 1 |
| Reichart, PA | 1 |
| Pohle, HD | 3 |
| Shibuya, Y | 1 |
| Kitamura, S | 1 |
| Sohara, Y | 1 |
| Saitoh, K | 1 |
| Page, B | 1 |
| Thervet, E | 1 |
| Legendre, C | 1 |
| Kreis, H | 1 |
| Goenka, MK | 1 |
| Mehta, S | 1 |
| Yachha, SK | 1 |
| Nagi, B | 1 |
| Chakraborty, A | 1 |
| Malik, AK | 1 |
| Gurevitz, O | 1 |
| Goldschmied-Reuven, A | 1 |
| Block, C | 1 |
| Kopolovic, J | 1 |
| Farfel, Z | 1 |
| Hassin, D | 1 |
| Tanaka, K | 1 |
| Kohno, S | 2 |
| Maesaki, S | 1 |
| Mitsutake, K | 1 |
| Miyazaki, H | 1 |
| Miyazaki, T | 1 |
| Tomono, K | 1 |
| Kaku, M | 1 |
| Koga, H | 2 |
| Hara, K | 1 |
| Tabone, MD | 1 |
| Leverger, G | 1 |
| Landman, J | 1 |
| Aznar, C | 1 |
| Boccon-Gibod, L | 1 |
| Lasfargues, G | 1 |
| Donnet, A | 1 |
| Graziani, N | 1 |
| Harlé, JR | 1 |
| Durand, JM | 1 |
| Touta, A | 1 |
| Grisoli, F | 1 |
| St Georgiev, V | 2 |
| Sato, M | 1 |
| Saku, N | 1 |
| Takeda, A | 2 |
| Suzuki, N | 1 |
| Saito, T | 1 |
| Minato, N | 1 |
| Saito, K | 1 |
| Kano, S | 2 |
| Malik, R | 2 |
| Craig, AJ | 1 |
| Wigney, DI | 2 |
| Martin, P | 1 |
| Love, DN | 2 |
| Mahida, P | 1 |
| Morar, R | 1 |
| Goolam Mahomed, A | 1 |
| Song, E | 1 |
| Tissandie, JP | 1 |
| Feldman, C | 1 |
| Finazzi, R | 1 |
| Guffanti, M | 1 |
| Cernuschi, M | 1 |
| Erembourg, L | 1 |
| Capasso, G | 1 |
| Ossi, C | 1 |
| Gesu, G | 1 |
| Benard, G | 1 |
| Gryschek, RC | 1 |
| Duarte, AJ | 1 |
| Shikanai-Yasuda, MA | 1 |
| Wendisch, J | 1 |
| Kaulen, F | 1 |
| Schwarze, R | 1 |
| Kabus, M | 1 |
| Aberg, JA | 1 |
| Medeiros, C | 1 |
| Sanchez-Albisua, B | 1 |
| Rodriguez-Peralto, JL | 1 |
| Romero, G | 1 |
| Alonso, J | 1 |
| Vanaclocha, F | 1 |
| Iglesias, L | 1 |
| Cubo Delgado, E | 1 |
| Sanz Boza, R | 1 |
| Garcia Urra, D | 1 |
| Barquero Jimenez, S | 1 |
| Vargas Castrillon, E | 1 |
| Feldmesser, M | 1 |
| Mukherjee, J | 1 |
| Casadevall, A | 1 |
| Rostomian, K | 1 |
| Dugel, PU | 1 |
| Kolahdouz-Isfahani, A | 1 |
| Thach, AB | 1 |
| Smith, RE | 1 |
| Rao, NA | 1 |
| Espinel-Ingroff, A | 2 |
| Kitano, M | 1 |
| Takeuchi, Y | 1 |
| Matsui, T | 1 |
| Asakura, S | 1 |
| Fujio, A | 1 |
| Aihara, M | 1 |
| Berenguer Berenguer, J | 1 |
| Parisi, A | 1 |
| Malfitano, A | 1 |
| Bruno, R | 1 |
| Calderon, W | 1 |
| Sacchi, P | 1 |
| Patruno, SF | 1 |
| Filice, G | 1 |
| Doi, SA | 1 |
| Tan, CT | 1 |
| Liam, CK | 2 |
| Naganathan, K | 1 |
| Gayowski, T | 1 |
| Marino, IR | 1 |
| Melzer, M | 1 |
| Colbridge, M | 1 |
| Keenan, F | 1 |
| Stainsby, D | 1 |
| Ong, EL | 1 |
| Menon, BS | 1 |
| Shuaib, IL | 1 |
| Zamari, M | 1 |
| Haq, JA | 1 |
| Aiyar, S | 1 |
| Noh, LM | 1 |
| Hospenthal, DR | 1 |
| Coccia, L | 1 |
| Calista, D | 1 |
| Boschini, A | 1 |
| Kordossis, T | 1 |
| Avlami, A | 1 |
| Velegraki, A | 1 |
| Stefanou, I | 1 |
| Georgakopoulos, G | 1 |
| Papalambrou, C | 1 |
| Legakis, NJ | 1 |
| Alonso, M | 1 |
| García, F | 1 |
| Mallolas, J | 2 |
| Soriano, A | 1 |
| Ortega, M | 1 |
| Miró, JM | 2 |
| Gatell, JM | 2 |
| Soriano, E | 2 |
| Martínez Fernández, EM | 1 |
| López-Cortés, LF | 1 |
| Regordan, C | 1 |
| Cordero Matía, E | 1 |
| de Pauw, BE | 1 |
| Meunier, F | 1 |
| Wong, CM | 1 |
| Lim, KH | 1 |
| Orni-Wasserlauf, R | 1 |
| Izkhakov, E | 1 |
| Siegman-Igra, Y | 1 |
| Bash, E | 1 |
| Polacheck, I | 2 |
| Giladi, M | 1 |
| Rodero, L | 1 |
| Cahn, P | 1 |
| Hochenfellner, F | 1 |
| Canteros, C | 1 |
| Kaufman, S | 1 |
| Guelfand, L | 1 |
| Chang, SC | 1 |
| Shih, CC | 1 |
| Hung, CC | 1 |
| Luhbd, KT | 1 |
| Pan, YS | 1 |
| Hsieh, WC | 1 |
| Govender, S | 1 |
| Mutasa, E | 1 |
| Parbhoo, AH | 1 |
| Barchiesi, F | 1 |
| Schimizzi, AM | 1 |
| Najvar, LK | 1 |
| Bocanegra, R | 1 |
| Caselli, F | 1 |
| Di Cesare, S | 1 |
| Giannini, D | 1 |
| Di Francesco, LF | 1 |
| Giacometti, A | 1 |
| Carle, F | 1 |
| Scalise, G | 1 |
| André, MH | 1 |
| Rollot, F | 1 |
| Bossi, P | 1 |
| Tubiana, R | 1 |
| Caumes, E | 1 |
| Zeller, V | 1 |
| Katlama, C | 1 |
| Bricaire, F | 1 |
| Cook, PP | 1 |
| Friese, G | 1 |
| Discher, T | 1 |
| Füssle, R | 1 |
| Schmalreck, A | 1 |
| Lohmeyer, J | 1 |
| Rambeloarisoa, J | 1 |
| Batisse, D | 1 |
| Thiebaut, JB | 1 |
| Mikol, J | 1 |
| Mrejen, S | 1 |
| Karmochkine, M | 1 |
| Kazatchkine, MD | 1 |
| Weiss, L | 1 |
| Piketty, C | 1 |
| Bennet, JE | 1 |
| Chleboun, J | 1 |
| Nade, S | 1 |
| Sneller, MR | 1 |
| Hariri, A | 1 |
| Sorenson, WG | 1 |
| Larsh, HW | 1 |
| Lai, YH | 1 |
| Tsai, JH | 1 |
| Chen, CY | 1 |
| Shadomy, S | 4 |
| Seeliger, HP | 2 |
| Beyt, BE | 1 |
| Waltman, SR | 1 |
| Jimbow, T | 1 |
| Tejima, Y | 1 |
| Ikemoto, H | 2 |
| Mitchell, LF | 1 |
| Drutz, DJ | 1 |
| Codish, SD | 2 |
| Tobias, JS | 2 |
| Monaco, AP | 2 |
| Berendes, K | 1 |
| Engelke, W | 1 |
| Dörstelmann, D | 1 |
| Nobrega, JP | 3 |
| Livramento, JA | 2 |
| Machado, LR | 1 |
| Spina-França, A | 2 |
| Wilkinson, GT | 1 |
| Poliner, JR | 1 |
| Wilkins, EB | 1 |
| Fernald, GW | 1 |
| Fusner, JE | 1 |
| McClain, KL | 1 |
| Weir, EC | 1 |
| Schwartz, A | 1 |
| Buergelt, CD | 1 |
| Duma, RJ | 2 |
| Medoff, G | 3 |
| Sande, MA | 3 |
| Gallis, H | 1 |
| Leonard, J | 1 |
| Fields, BT | 1 |
| Bradshaw, M | 1 |
| Haywood, H | 1 |
| McGee, ZA | 1 |
| Cate, TR | 2 |
| Cobbs, CG | 1 |
| Warner, JF | 2 |
| Alling, DW | 1 |
| Graham, DR | 1 |
| Last, JA | 1 |
| Cross, CE | 1 |
| Williams, KM | 1 |
| Chinwah, PM | 1 |
| Cobcroft, R | 1 |
| Drouhet, E | 1 |
| Stewart, JD | 1 |
| Bryan, CS | 1 |
| McFarland, JA | 1 |
| Saunders, AM | 1 |
| Goolden, AW | 1 |
| Darrell, AH | 1 |
| Gross, PA | 1 |
| Patel, C | 1 |
| Spitler, LE | 1 |
| Marier, R | 1 |
| Zakhireh, B | 1 |
| Downs, J | 1 |
| Wynne, B | 1 |
| Hammond, GL | 1 |
| Andriole, VT | 2 |
| Holt, RJ | 1 |
| Diasio, RB | 3 |
| Lakings, DE | 1 |
| Schröter, GP | 1 |
| Temple, DR | 1 |
| Husberg, BS | 1 |
| Weil, R | 1 |
| Starzl, TE | 1 |
| Kauffman, CA | 3 |
| Carleton, JA | 1 |
| Frame, PT | 1 |
| Tolentino, P | 1 |
| Borrone, C | 1 |
| Krick, JA | 1 |
| Remington, JS | 1 |
| Robert, L | 1 |
| Piersantelli, N | 1 |
| Speller, DC | 1 |
| Fakunle, F | 1 |
| Cairns, SA | 1 |
| Stephens, M | 1 |
| Friedlander, M | 1 |
| Gelfand, M | 1 |
| Condon, PI | 1 |
| Richardson, PM | 1 |
| Mohandas, A | 1 |
| Arumugasamy, N | 2 |
| Wrigley, PF | 1 |
| Shaw, E | 1 |
| Chand, K | 1 |
| Lall, KS | 1 |
| Kim, SH | 1 |
| Yun, DJ | 1 |
| Kim, TS | 1 |
| Hsi, MS | 1 |
| Chen, RC | 1 |
| Hung, TP | 1 |
| Hamilton, JD | 2 |
| Elliott, DM | 1 |
| Belcher, RW | 1 |
| Palazij, R | 1 |
| Wolinsky, E | 1 |
| Martin, RA | 1 |
| Bates, D | 1 |
| Shaw, DA | 1 |
| Lissoir, FG | 1 |
| Laterre, EC | 1 |
| Vandepitte, J | 1 |
| Blaton, H | 1 |
| Yourassowsky, E | 1 |
| Schouttens, E | 1 |
| Harder, EJ | 2 |
| Barfuss, T | 1 |
| Snow, RM | 1 |
| Berman, RA | 1 |
| Gunnells, JC | 1 |
| Stickel, DL | 1 |
| Stretcher, GS | 1 |
| Smith, JG | 1 |
| Cartwright, RY | 1 |
| Kobayashi, GS | 1 |
| Salit, I | 1 |
| Hand, R | 1 |
| Fischman, O | 1 |
| de Camargo, ZP | 1 |
| Grinblat, M | 1 |
| Drevets, CC | 1 |
| Hummer, LM | 1 |
| Meinhof, W | 1 |
| Utz, JP | 2 |
| Garriques, IL | 1 |
| Mandell, GL | 1 |
| McGehee, RF | 1 |
| Van Cutsem, J | 1 |
| Bava, AJ | 1 |
| Negroni, R | 1 |
| Schaberg, T | 1 |
| Lode, H | 1 |
| Kaminski, ZC | 1 |
| Kapila, R | 2 |
| Sharer, LR | 1 |
| Kloser, P | 1 |
| Kaufman, L | 2 |
| Sorensen, RU | 1 |
| Boehm, KD | 1 |
| Kaplan, D | 1 |
| Berger, M | 1 |
| Nishii, K | 1 |
| Kodani, T | 1 |
| Uji, H | 1 |
| Moritani, Y | 1 |
| Ohnoshi, T | 1 |
| Hiraki, S | 1 |
| Ueoka, H | 1 |
| Numata, T | 1 |
| Maeda, T | 1 |
| Kimura, I | 1 |
| Hester, DE | 1 |
| Kylstra, JA | 1 |
| Eifrig, DE | 1 |
| Pedrol, E | 1 |
| González-Clemente, JM | 1 |
| Azón, A | 1 |
| Moreno, A | 1 |
| Mensa, J | 1 |
| Crump, JR | 1 |
| Elner, SG | 1 |
| Elner, VM | 1 |
| Mitchell, DH | 1 |
| Gazapo Carretero, E | 1 |
| García Aguado, C | 1 |
| Adrados de Llano, M | 1 |
| Martínez Blanco, ML | 1 |
| Verdejo Ortes, J | 1 |
| González Lahoz, JM | 1 |
| Amundson, DE | 1 |
| al-Rasheed, SA | 1 |
| al-Fawaz, IM | 1 |
| Buxton, MJ | 1 |
| Dubois, DJ | 1 |
| Turner, RR | 1 |
| Sculpher, MJ | 1 |
| Robinson, PA | 1 |
| Searcy, C | 1 |
| Sugar, AM | 1 |
| Shindo, K | 2 |
| Kennedy, CA | 2 |
| Goetz, MB | 3 |
| Mathisen, GE | 1 |
| Bozzette, SA | 1 |
| Larsen, RA | 2 |
| Chiu, J | 1 |
| Leal, MA | 2 |
| Jacobsen, J | 1 |
| Rothman, P | 1 |
| Robinson, P | 1 |
| Gilbert, G | 1 |
| McCutchan, JA | 1 |
| Tilles, J | 1 |
| Allendoerfer, R | 1 |
| Marquis, AJ | 1 |
| Rinaldi, MG | 1 |
| Ruf, B | 1 |
| Chan, LS | 1 |
| Laroche, R | 1 |
| Deppner, M | 1 |
| Floch, JJ | 1 |
| Kadende, P | 1 |
| Goasguen, J | 1 |
| Saunière, JF | 1 |
| Nelson, MR | 1 |
| Bower, M | 1 |
| Smith, D | 1 |
| Reed, C | 1 |
| Shanson, D | 1 |
| Gazzard, B | 1 |
| Wong, RD | 1 |
| Scheld, WM | 1 |
| Schmutzhard, E | 3 |
| Boongird, P | 2 |
| Gerstenbrand, F | 1 |
| Jitpimolmard, S | 2 |
| Ponglikitmongkol, S | 1 |
| Vejjajiva, A | 2 |
| Reents, SB | 1 |
| Powell, G | 1 |
| Carney, MD | 1 |
| Combs, JL | 1 |
| Waschler, W | 1 |
| Matsuda, O | 1 |
| Hiruma, M | 1 |
| Makiguchi, K | 1 |
| Tsutsui, H | 1 |
| Chida, Y | 1 |
| Ida, T | 1 |
| Malumo, F | 1 |
| Cochius, JI | 1 |
| Burns, RJ | 1 |
| Willoughby, JO | 1 |
| Picon, L | 1 |
| Vaillant, L | 1 |
| Duong, T | 1 |
| Lorette, G | 1 |
| Bacq, Y | 1 |
| Besnier, JM | 1 |
| Choutet, P | 1 |
| Rajendran, C | 1 |
| Mehndiratta, MM | 1 |
| Kumari, S | 1 |
| Gupta, M | 1 |
| Sehgal, S | 1 |
| Kofler, H | 1 |
| Fritsch, P | 1 |
| Kaczmarski, EB | 1 |
| Tooth, JA | 1 |
| Anastassiades, E | 1 |
| Manos, J | 1 |
| Gokal, R | 1 |
| Hernandez, AD | 1 |
| Chuck, SL | 1 |
| Mathisen, G | 1 |
| Chin, CS | 1 |
| Cheong, YM | 1 |
| Wong, YH | 1 |
| Mocan, H | 1 |
| Murphy, AV | 1 |
| Beattie, TJ | 1 |
| McAllister, TA | 1 |
| Mizuno, T | 1 |
| Matsumoto, Y | 1 |
| Hashimoto, Y | 1 |
| Matsumura, M | 1 |
| Ito, A | 1 |
| Shionoiri, H | 1 |
| Weinke, T | 1 |
| Rögler, G | 2 |
| Sixt, C | 1 |
| de Matos-Marques, B | 1 |
| Staib, F | 4 |
| Seibold, M | 3 |
| Nowack, WJ | 1 |
| Bradsher, RW | 1 |
| Sugishima, H | 1 |
| Shimotuma, N | 1 |
| Itagaki, N | 1 |
| Hasegawa, H | 1 |
| Horiuchi, A | 1 |
| Vejajjiva, A | 1 |
| Wszolek, Z | 1 |
| Monsour, H | 1 |
| Smith, P | 1 |
| Pfeiffer, R | 1 |
| Mina, FA | 1 |
| Hopkins, SJ | 1 |
| Richelo, B | 1 |
| Niikawa, S | 1 |
| Hara, A | 1 |
| Nokura, H | 1 |
| Uno, T | 1 |
| Ohkuma, A | 1 |
| Yamada, H | 1 |
| Orefice, G | 1 |
| Carrieri, PB | 1 |
| Vecchione, V | 1 |
| Chirianni, A | 1 |
| Tullio-Cataldo, P | 1 |
| Striano, S | 1 |
| Chea, R | 1 |
| Morales, J | 1 |
| Mocarquer, A | 1 |
| Aris, L | 1 |
| James, E | 1 |
| Segovia, L | 1 |
| Castillo, J | 1 |
| Moyano, C | 1 |
| Cloud, G | 1 |
| Kerkering, TM | 1 |
| Kaplowitz, LG | 1 |
| Fisher, JF | 1 |
| Gregg, CR | 1 |
| Bowles, CA | 2 |
| Soong, S | 1 |
| Blackwelder, WC | 1 |
| Cloud, GA | 1 |
| Karam, GH | 1 |
| Schulman, JA | 1 |
| Leveque, C | 1 |
| Coats, M | 1 |
| Lawrence, L | 1 |
| Barber, JC | 1 |
| Sacks, T | 1 |
| Baldwin, S | 1 |
| Stagno, S | 1 |
| Odrezin, GT | 1 |
| Kelly, DR | 1 |
| Whitley, RJ | 1 |
| Leavitt, AD | 1 |
| Muramoto, T | 1 |
| Ohi, T | 1 |
| Nishimura, K | 1 |
| Lucentini, MO | 1 |
| Del Prado, C | 1 |
| Mattera, RS | 1 |
| Tiraboschi, NI | 1 |
| Meyer, RD | 1 |
| Eng, RH | 1 |
| Bishburg, E | 1 |
| Smith, SM | 1 |
| Doutsu, Y | 1 |
| Masaki, M | 1 |
| Masuyama, Y | 1 |
| Yamashita, K | 1 |
| Oka, M | 1 |
| Shigeno, Y | 1 |
| Kanda, T | 1 |
| Yamaguchi, K | 1 |
| Waterston, JA | 1 |
| Gilligan, BS | 1 |
| Guérin, JM | 1 |
| Lebiez, PE | 1 |
| Segrestaa, JM | 1 |
| Panciera, DL | 1 |
| Bevier, D | 1 |
| Sa'adah, MA | 1 |
| Shakir, RA | 1 |
| Jadaa, SI | 1 |
| Bezjak, V | 1 |
| Araj, GF | 1 |
| Prüfer-Krämer, L | 1 |
| Eichenlaub, D | 1 |
| Bussone, G | 1 |
| La Mantia, L | 1 |
| Parati, EA | 1 |
| Frediani, F | 1 |
| Lamperti, E | 1 |
| Boiardi, A | 1 |
| Peccarisi, C | 1 |
| Kimura, K | 1 |
| Hatakeyama, M | 1 |
| Miyagi, J | 1 |
| Sumiya, M | 1 |
| Takaku, F | 1 |
| Yamamoto, K | 1 |
| Sandstrom, PA | 1 |
| Kojima, T | 1 |
| Matsuzaki, M | 1 |
| Sano, M | 1 |
| Suzuki, H | 1 |
| Hino, Y | 1 |
| Nagura, E | 1 |
| Saito, H | 1 |
| Watson, AJ | 1 |
| Russell, RP | 1 |
| Cabreja, RF | 1 |
| Braverman, R | 1 |
| Whelton, A | 1 |
| Kovacs, JA | 1 |
| Kovacs, AA | 1 |
| Polis, M | 1 |
| Wright, WC | 1 |
| Gill, VJ | 1 |
| Tuazon, CU | 1 |
| Gelmann, EP | 1 |
| Lane, HC | 1 |
| Longfield, R | 1 |
| Overturf, G | 1 |
| Zuger, A | 1 |
| Louie, E | 1 |
| Holzman, RS | 1 |
| Simberkoff, MS | 1 |
| Rahal, JJ | 1 |
| Brennan, M | 1 |
| Morgan, HJ | 1 |
| Bohle, C | 1 |
| Sinn, M | 1 |
| Werner, E | 1 |
| Biniek, R | 1 |
| Hilgenstock, F | 1 |
| Schuchardt, V | 1 |
| Sabetta, JR | 1 |
| Matsushita, T | 1 |
| Suzuki, K | 1 |
| Mitchell, RT | 1 |
| Marshall, LH | 1 |
| Lefkowitz, LB | 1 |
| Stratton, CW | 1 |
| Tjia, TL | 1 |
| Yeow, YK | 1 |
| Tan, CB | 1 |
| Maslan, MJ | 1 |
| Graham, MD | 1 |
| Flood, LM | 1 |
| McCluskey, PJ | 1 |
| Wakefield, D | 1 |
| Plotkin, SA | 1 |
| Neuhaus, F | 1 |
| Seeliger, H | 1 |
| Tympner, KD | 1 |
| Tümbay, E | 1 |
| Lamotte-Barrillon, S | 1 |
| Maillard, JN | 1 |
| Carbon, C | 1 |
| Barge, J | 1 |
| Boussougant, Y | 1 |
| Docquir, C | 1 |
| Aitken, G | 1 |
| Singhal, BS | 1 |
| Veer, AS | 1 |
| Pastakia, LF | 1 |
| Reichelderfer, TE | 1 |
| Fraga, JR | 1 |
| Mirza, AM | 1 |
| Stanton, KG | 1 |
| Sanderson, CR | 1 |
| Zylstra, W | 1 |
| Roberts, M | 1 |
| Rinaudo, PA | 1 |
| Tilton, RC | 1 |
| Vilinskas, J | 1 |
| Block, ER | 1 |
| Schönebeck, J | 1 |
| Anséhn, S | 1 |
| Philpot, CR | 1 |
| Lo, D | 1 |
| Meyer, R | 1 |
| Axelrod, JL | 1 |
| Nathan, CF | 1 |
| Briggs, DR | 1 |
| Barney, PL | 1 |
| Bahu, RM | 1 |
| Halkin, H | 1 |
| Ravid, M | 1 |
| Zulman, J | 1 |
| Reichert, N | 1 |
| Firkin, FC | 1 |
| Newberry, WM | 1 |
| Abernathy, RS | 1 |
| Neu, HC | 1 |
| van den Ende, EW | 1 |
| Hammond, JA | 1 |
| Amoils, RL | 1 |
| Lefton, HB | 1 |
| Farmer, RG | 1 |
| Buchwald, R | 1 |
| Haselby, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cryptococcosis in Previously Healthy Adults[NCT00001352] | 800 participants (Anticipated) | Observational | 1993-04-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
38 reviews available for flucytosine and C gattii Infection
| Article | Year |
|---|---|
Cryptococcosis in domestic and wild animals: A review.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Ferrets; Fluc | 2023 |
Searching for new antifungals for the treatment of cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine | 2023 |
Cryptococcosis caused by cryptococcus gattii: 2 case reports and literature review.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Asian Peopl | 2020 |
Cryptococcal meningoencephalitis: time for action.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Databases, Factual; Deoxycholic Acid; Drug Combin | 2021 |
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine | 2015 |
Managing cryptococcosis in the immunocompromised host.
Topics: Amphotericin B; Antifungal Agents; Case Management; Cryptococcosis; Drug Therapy, Combination; Flucy | 2008 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Flucytosine; Humans; Imidazoles; Myc | 1983 |
[Current treatment of systematic mycoses].
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; | 1983 |
Fungal arthritis. V. Cryptococcal and histoplasmal arthritis.
Topics: Adult; Aged; Amphotericin B; Arthritis, Infectious; Cryptococcosis; Female; Flucytosine; Histoplasmo | 1980 |
Management of cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Lung Dis | 1993 |
[Neurological form of cryptococcosis. Apropos of 2 atypical cases in non HIV-infected patients].
Topics: Adolescent; Adult; Agammaglobulinemia; Amphotericin B; Brain Abscess; Brain Diseases; Cryptococcosis | 1993 |
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. I. Cryptococcosis.
Topics: Amphotericin B; Animals; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Com | 1993 |
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. II. Cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Cross Infection; Cryptococcosis; D | 1993 |
[A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan].
Topics: Arthritis, Rheumatoid; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; | 1993 |
Cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Azoles; Clinical Trials as | 1997 |
Clinical relevance of antifungal resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial; | 1997 |
[Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Clinical T | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis | 1999 |
Current approach to the acute management of cryptococcal infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Cryp | 2000 |
[Cryptococcosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Child; Cryptococcos | 2001 |
Flucytosine.
Topics: Amphotericin B; Candidiasis; Chromoblastomycosis; Cryptococcosis; Cytosine; Drug Therapy, Combinatio | 1977 |
Skeletal cryptococcosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Bone Diseases; Cryptococcosis; Diagnosis, Differential; Fem | 1977 |
Feline cryptococcosis: a review and seven case reports.
Topics: Amphotericin B; Animals; Cat Diseases; Cats; Cryptococcosis; Diagnosis, Differential; Female; Flucyt | 1979 |
Opportunistic invasive fungal infections in patients with leukaemia lymphoma.
Topics: Acute Disease; Adrenal Cortex Hormones; Amphotericin B; Aspergillosis; Blood Transfusion; Candidiasi | 1976 |
[Special therapeutic aspects of cryptococcal meningoencephalitis].
Topics: Amphotericin B; Antifungal Agents; Child; Clotrimazole; Cryptococcosis; Cryptococcus neoformans; Dru | 1976 |
Antifungal drugs.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Blastomycosis; Candicidin; Candidiasis; C | 1975 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomy | 1992 |
Cryptococcal endophthalmitis: case report and review.
Topics: Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Endophthalmitis; Eye Infections, Fung | 1992 |
Overview: cryptococcosis in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans | 1991 |
[Cryptococcosis in AIDS: therapeutic concepts].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Fluco | 1990 |
Combination therapy in systemic mycosis.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combinatio | 1990 |
Cryptococcosis in the immunocompromised host.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunologic Deficiency Syndromes; Male; Middle | 1989 |
Cutaneous cryptococcosis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Biopsy; Cryptococcosis; Cryptococcus neoformans; | 1989 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Diagnosis of cryptococcosis and monitoring of chemotherapy.
Topics: Adolescent; Adult; Africa; Amphotericin B; Asia, Southeastern; Australia; Central Nervous System Dis | 1985 |
Drug treatment of the systemic mycoses.
Topics: Actinomycosis; Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidi | 1972 |
11 trials available for flucytosine and C gattii Infection
| Article | Year |
|---|---|
Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome?
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neofor | 2003 |
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, F | 1997 |
Flucytosine monotherapy for cryptococcosis.
Topics: Adult; Aged; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; | 1998 |
Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Ther | 2001 |
Comparison between 5-fluorocytosine, amphotericin B and the combined administration of these agents in the therapeutic effectiveness for cryptococcal meningitis.
Topics: Adult; Aged; Amphotericin B; Clinical Trials as Topic; Cryptococcosis; Cytosine; Drug Administration | 1978 |
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Cryptococcosis; Cytosine; Drug Evaluation; Drug Therapy, Co | 1979 |
A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Cryptococcosis; Double-Blind Method; Drug Evaluatio | 1991 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1990 |
Combination therapy in systemic mycosis.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combinatio | 1990 |
Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Child; Clinical Trials | 1987 |
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Child; Clinical Trials as Topic; Creatin | 1987 |
320 other studies available for flucytosine and C gattii Infection
| Article | Year |
|---|---|
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitiv | 2008 |
Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Topics: Adaptation, Physiological; Amphotericin B; Aneuploidy; Antifungal Agents; Cryptococcosis; Cryptococc | 2021 |
Multilocus sequence typing of strains from the Cryptococcus gattii species complex from different continents.
Topics: Cryptococcosis; Cryptococcus gattii; Fluconazole; Flucytosine; Genotype; Humans; Multilocus Sequence | 2022 |
Rapidly enlarging pulmonary mass due to immune reconstitution inflammatory syndrome (IRIS) in an immunocompetent host with pulmonary
Topics: Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Immune Reconstitution Inf | 2022 |
Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study.
Topics: Adult; Antifungal Agents; Cross-Sectional Studies; Cryptococcosis; Female; Fluconazole; Flucytosine; | 2022 |
Antifungal susceptibility of the clinical and environmental strains of Cryptococcus gattii sensu lato in Taiwan.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Drug Resist | 2023 |
Involvement of the Noncanonical Polyadenylation Polymerase Cid14 in Fungal Azole Resistance in the Pathogen Cryptococcus neoformans.
Topics: Adenosine Triphosphate; Animals; Azoles; Carbohydrates; Cryptococcosis; Cryptococcus neoformans; Flu | 2022 |
Cryptococcus neoformans Presenting as a Lung Mass in an Immunocompromised Patient.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; F | 2022 |
Factors Influencing the Nitrogen-Source Dependent Flucytosine Resistance in Cryptococcus Species.
Topics: Amino Acids; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Cytosi | 2023 |
Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Democratic Republic of t | 2023 |
Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Hu | 2023 |
Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Microbial S | 2023 |
Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; DNA, Fungal; Drug Resistance, Fungal; Fe | 2019 |
A Novel Role of Fungal Type I Myosin in Regulating Membrane Properties and Its Association with d-Amino Acid Utilization in Cryptococcus gattii.
Topics: Actins; Amino Acids; Amphotericin B; Antifungal Agents; Cell Membrane; Cell Membrane Permeability; C | 2019 |
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
Topics: Adult; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcosis; Cryptococcus; Cryptococcus ne | 2019 |
An AIDS patient with urine retention.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; China; Cryptococcosis; Cryptococcus neofor | 2019 |
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Topics: Amphotericin B; Animals; Antifungal Agents; Auranofin; Candida albicans; Candidiasis; Cell Line; Cic | 2020 |
Disseminated cutaneous cryptococcosis in an immunocompetent elderly long-term pigeon fancier.
Topics: Administration, Cutaneous; Aged; Animals; Antifungal Agents; Columbidae; Cryptococcosis; Cryptococcu | 2020 |
An Elderly Patient with Pulmonary Cryptococcosis with Mediastinal Lymphadenopathy Who Was Successfully Treated with Amphotericin B and Flucytosine.
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Dru | 2020 |
Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Cryptococcosis; Cry | 2021 |
Crazy-paving patterns as rare radiological manifestations of pulmonary cryptococcosis: a case report.
Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Cryptococcosis; Flucytosine; Humans; Lung Diseases, | 2021 |
Cryptococcal infection presenting as soft tissue abscess and arthritis: Case report.
Topics: Abscess; Aged; Antifungal Agents; Arthritis; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Dif | 2021 |
Progressive Cytopenia Developing during Treatment of Cryptococcosis in a Patient with HIV Infection and Bone Marrow Cryptococcal Infection.
Topics: Antifungal Agents; Bone Marrow; Cryptococcosis; Cryptococcus neoformans; Flucytosine; HIV Infections | 2022 |
Topics: Abscess; Acute Kidney Injury; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosin | 2017 |
Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.
Topics: Adult; Amphotericin B; Antifungal Agents; Chloramphenicol; Cote d'Ivoire; Cryptococcosis; Cryptococc | 2018 |
Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cytosine Deaminase; DNA Mutational Analysis; | 2018 |
Bilateral Asymptomatic Cryptococcal Retinitis without Choroiditis or Vitritis.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Choroiditis; Cryptococcosis; Cryptoc | 2018 |
Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Topics: Amphotericin B; Antifungal Agents; Brazil; Clinical Laboratory Techniques; Cryptococcosis; Cryptococ | 2019 |
In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.
Topics: Amphotericin B; Antifungal Agents; Benzene Derivatives; Cryptococcosis; Cryptococcus; Drug Synergism | 2019 |
Disseminated
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Cryptococcosis; Cryptococcu | 2019 |
Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Dru | 2013 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross | 2012 |
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.
Topics: Adult; Amphotericin B; Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Female; Fl | 2013 |
Feline nasal granuloma due to Cryptoccocus gattii type VGII.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Cryptococcosis; Cryptococcus gattii; Flucytosine; Gr | 2013 |
Pulmonary cryptococcosis and cryptococcal osteomyelitis mimicking primary and metastatic lung cancer in (18)F-FDG PET/CT.
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Fluorodeoxygluc | 2014 |
Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcosis; Cryptoco | 2014 |
Fulminant atypical Cryptococcus neoformans pneumonia confirmed by PLEX-ID.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coinfection; | 2014 |
Miliary pattern on chest imaging in an immunocompetent child.
Topics: Amphotericin B; Antifungal Agents; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Fema | 2014 |
Cryptococcus gattii osteomyelitis and compounded itraconazole treatment failure in a Pesquet's parrot (Psittrichas fulgidus).
Topics: Animals; Antifungal Agents; Bird Diseases; Cryptococcosis; Cryptococcus gattii; Drug Compounding; Fe | 2014 |
Pulmonary Cryptococcosis.
Topics: Adolescent; Antifungal Agents; Bronchoscopy; Cryptococcosis; Female; Flucytosine; Humans; Lung Disea | 2013 |
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococc | 2014 |
Neuro-ophthalmic presentations and treatment of Cryptococcal meningitis-related increased intracranial pressure.
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcu | 2014 |
Pulmonary cryptococcosis with endobronchial lesions and meningitis.
Topics: Amphotericin B; Animals; Bronchi; Bronchoscopy; Columbidae; Cryptococcosis; Cryptococcus neoformans; | 2014 |
Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.
Topics: Antifungal Agents; Cerebrospinal Fluid; Coinfection; Cryptococcosis; Cryptococcus neoformans; Flucyt | 2015 |
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
Topics: Brain; Cryptococcosis; Fingolimod Hydrochloride; Flucytosine; Humans; Male; Middle Aged; Multiple Sc | 2015 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; | 2016 |
Editorial Commentary: Life-saving Antimicrobial Drugs: What Are We Doing to Pricing and Availability?
Topics: Amphotericin B; Anti-Infective Agents; Costs and Cost Analysis; Cryptococcosis; Drug Therapy, Combin | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Dr | 2016 |
Cryptococcal cellulitis on the shin of an immunosuppressed patient.
Topics: Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Cyclosporine | 2016 |
Primary cutaneous cryptococcosis successfully managed by surgical debridement and liposomal amphotericin B/flucytosine therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Debridement; Dermatomycoses; Female; Flucyt | 2017 |
Cryptococcosis and deficiency of interleukin12r.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow; Candida albicans; Child, Preschool; Cryptococcosis; | 2008 |
Major role for amphotericin B-flucytosine combination in severe cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Com | 2008 |
Disseminated cryptococcal infection with eosinophilia in a healthy person.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Eosinophilia; F | 2008 |
Pulmonary cryptococcosis in non-AIDS patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Fem | 2009 |
Hepatic involvement in a liver transplant recipient with disseminated cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Fatal Outcome; Flucytosine; Humans; Immunosuppres | 2009 |
Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure.
Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus; Culture Media; | 2009 |
Intraocular cryptococcoma.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Comb | 2009 |
Disseminated Cryptococcus neoformans: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Liv | 2009 |
JAAD grand rounds quiz*: Renal transplant patient with vegetative plaque on the cheek.
Topics: Amphotericin B; Cheek; Cryptococcosis; Cryptococcus neoformans; Facial Dermatoses; Flucytosine; Huma | 2010 |
Cryptococcosis in sarcoidosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Hu | 2010 |
Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Comb | 2011 |
74-year-old man from the pacific northwest with fever and a lung mass.
Topics: Aged; Amphotericin B; Antifungal Agents; British Columbia; Bromhexine; Cryptococcosis; Cryptococcus | 2011 |
[Skin lesions and fever in an VIH-infected patient].
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; F | 2012 |
A flucytosine-responsive Mbp1/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Cell Membrane; Colony Count, Microbial; Conserved S | 2012 |
Cryptococcal osteomyelitis of the scapula and rib in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Drug C | 2012 |
Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.
Topics: Amphotericin B; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug | 2012 |
Disseminated cryptococcosis revealed by vertebral osteomyelitis in an immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Cryptococcosis; Cryptococcus neoformans; Flucytosi | 2012 |
Photo quiz: a 38-year-old male with a 3-month history of abdominal pain, constipation, and headache.
Topics: Abdominal Pain; Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; CD4 Ly | 2012 |
Successful treatment of cryptococcal osteomyelitis and paraspinous abscess.
Topics: Abscess; Antifungal Agents; Cryptococcosis; Fluconazole; Flucytosine; Humans; Osteomyelitis; Thoraci | 2002 |
Cryptococcus neoformans infection.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Drug Therapy | 2002 |
Cryptococcal infection in sarcoidosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Mal | 2002 |
A flucytosine-resistant Cryptococcus neoformans (serotype D) strain isolated in turkey from cutaneous lesions.
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Drug Resistance, Fun | 2002 |
Phenotyping of Cryptococcus neoformans strains in Bergamo, Italy (1985-2000).
Topics: Adult; Agglutination Tests; Amphotericin B; Antifungal Agents; Azoles; Cell Adhesion; Cryptococcosis | 2003 |
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; F | 2003 |
CHEMOTHERAPEUTIC ACTIVITY OF 5-FLUOROCYTOSINE.
Topics: Antifungal Agents; Cryptococcosis; Flucytosine; Mice; Pharmacology; Research; Toxicology | 1963 |
Persistent cellulitis in a patient receiving renal dialysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Diagn | 2003 |
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.
Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; | 2004 |
Bilateral cryptococcal choroiditis.
Topics: Adult; Antifungal Agents; Choroiditis; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Eye | 2004 |
Disseminated infection with Cryptococcus neoformans var neoformans in an 8 years immunocompetent girl.
Topics: Antifungal Agents; Child; Cryptococcosis; Female; Flucytosine; Humans; Immunocompetence | 2005 |
Management of cryptococcosis in non-HIV-related patients.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antifungal Agents; Central Nervous System F | 2005 |
Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Disease | 2006 |
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococc | 2006 |
Molluscum or a mimic?
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Ther | 2006 |
Images in HIV/AIDS. Pruritic cryptococcal skin lesions in an HIV-positive person.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Dia | 2006 |
Colonic cryptococcus infection.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Colitis; Colonoscopy; Cryptococcosis; Cryptococcus | 2007 |
Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cry | 2007 |
Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Base Sequence; Cryptococcosis; Cryptococcus; Diagnosi | 2007 |
Granulomatous prostatitis due to Cryptococcus neoformans: diagnostic usefulness of special stains and molecular analysis of 18S rDNA.
Topics: Abscess; Amphotericin B; Antifungal Agents; Carmine; Coloring Agents; Cryptococcosis; Cryptococcus n | 2008 |
Reversible cardiomyopathy following treatment with amphotericin B and flucytosine.
Topics: Amphotericin B; Antifungal Agents; Blood Pressure; Cardiomyopathies; Cryptococcosis; Drug Carriers; | 2008 |
[Cryptococcus neoformans meningoencephalitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Hum | 1984 |
Ultrastructure of Cryptococcus neoformans.
Topics: Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Flucytosine; Humans; Microscopy, Electron | 1982 |
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug The | 1982 |
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergi | 1982 |
[Iatrogenic colitis during flucytosine treatment for neuromeningeal cryptococcosis].
Topics: Colitis; Cryptococcosis; Cytosine; Flucytosine; Humans; Male; Meningitis; Middle Aged | 1983 |
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug The | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergill | 1984 |
Cryptococcemia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Femal | 1983 |
Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome.
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Endoscopy; Esophageal Diseases; Fluc | 1984 |
Pulmonary mycosis in pregnant women.
Topics: Adult; Amphotericin B; Blastomycosis; Coccidioides; Coccidioidomycosis; Cryptococcosis; Estradiol; F | 1984 |
Treatment of cryptococcal meningitis with pulmonary granuloma.
Topics: Adult; Cryptococcosis; Flucytosine; Granuloma; Humans; Lung Diseases; Male; Meningitis; Miconazole | 1984 |
[Cryptococcus neoformans infection. Illustrated by a case of meningitis].
Topics: Aged; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male; Meningoencephalitis | 1983 |
[Clinical, diagnostic and therapeutic aspects of cryptococcal infection].
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Injections, Spinal; Meningitis; Prognosis | 1980 |
Cryptococcal meningitis: complications due to intrathecal treatment.
Topics: Amphotericin B; Catheterization; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Hum | 1980 |
Intrathecal cryptococcal lesion of the cauda equina successfully treated with intrathecal amphotericin B: A case report.
Topics: Adolescent; Amphotericin B; Cauda Equina; Cryptococcosis; Flucytosine; Granuloma; Humans; Injections | 1980 |
Ocular cryptococcosis in New Zealand.
Topics: Adult; Amphotericin B; Cryptococcosis; Eye Diseases; Female; Flucytosine; Humans; Lung Abscess | 1980 |
Disseminated cryptococcosis after transurethral resection of the prostate.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prost | 1982 |
[Cryptococcal meningoencephalitis functioning as expansive process. Report of a case].
Topics: Adult; Amphotericin B; Biopsy; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; F | 1980 |
Peritoneal clearance of amphotericin B and 5-fluorocytosine.
Topics: Amphotericin B; Cryptococcosis; Cytosine; Flucytosine; Humans; Kidney Transplantation; Male; Middle | 1980 |
Disseminated cutaneous cryptococcosis.
Topics: Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Female; Flucytosine; | 1981 |
Cryptococcal meningitis. A review of 32 years experience.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antigens, Fungal; Australia; Child; Cryptococcosis; Cryptoc | 1982 |
[Cutaneous cryptococcosis (author's transl)].
Topics: Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Flucytosine; Humans; Male; Middle Aged | 1982 |
[Cryptococcosis of the CNS].
Topics: Amphotericin B; Bacteriological Techniques; Cryptococcosis; Diagnosis, Differential; Flucytosine; Hu | 1982 |
Cryptococcal osteomyelitis. Report of a case amd a review of the literature.
Topics: Amphotericin B; Child; Cryptococcosis; Female; Flucytosine; Humans; Osteomyelitis | 1982 |
Antemortem diagnosis and treatment of cryptococcal meningitis in a horse.
Topics: Amphotericin B; Animals; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Horse Dis | 1982 |
Ulcerating enteritis associated with flucytosine therapy.
Topics: Aged; Amphotericin B; Biopsy; Cryptococcosis; Cytosine; Diarrhea; Flucytosine; Humans; Ileitis; Ileu | 1982 |
Success with amphotericin B and 5-fluorocytosine in treating cerebral cryptococcoma accompanying cryptococcal meningitis.
Topics: Adult; Amphotericin B; Brain Diseases; Cryptococcosis; Cytosine; Flucytosine; Humans; Male; Meningit | 1982 |
Treatment of feline nasal cryptococcosis with 5-flucytosine.
Topics: Animals; Cat Diseases; Cats; Cryptococcosis; Cytosine; Female; Flucytosine; Nose Diseases | 1982 |
[Usefulness of computed tomography in the diagnosis of cryptococcal meningoencephalitis--multiple low density lesions in the basal ganglia and corona radiata].
Topics: Adult; Amphotericin B; Basal Ganglia; Cryptococcosis; Female; Flucytosine; Humans; Male; Meningoence | 1982 |
Cryptococcosis in the United Kingdom and the Irish Republic: an analysis of 69 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Amphotericin B; Antigens, Fungal; Child; Collagen | 1980 |
Endogenous cryptococcal endophthalmitis.
Topics: Amphotericin B; Cryptococcosis; Eye Diseases; Female; Flucytosine; Humans; Middle Aged | 1981 |
Cryptococcal meningitis in pregnancy.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Meningitis; Pregnanc | 1981 |
[Cryptococcus neoformans. An unusual cause of basal meningitis. Case report (author's transl)].
Topics: Adult; Amphotericin B; Cryptococcosis; Diagnosis, Differential; Drug Therapy, Combination; Female; F | 1981 |
[Cryptococcosis in the light of three cases (author's transl)].
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Male; Meningitis; Midd | 1980 |
[Treatment of cryptococcosis with flucytosine].
Topics: Cryptococcosis; Cytosine; Flucytosine; Humans | 1980 |
Management of central nervous system cryptococcosis.
Topics: Amphotericin B; Brain Diseases; Central Nervous System Diseases; Cryptococcosis; Flucytosine; Humans | 1980 |
Cryptococcosis in the West Indies.
Topics: Adolescent; Adult; Aged; Cryptococcosis; Female; Flucytosine; Humans; Male; Meningitis; Middle Aged; | 1980 |
Cutaneous cryptococcosis.
Topics: Adult; Amphotericin B; Cryptococcosis; Dermatomycoses; Drug Therapy, Combination; Female; Flucytosin | 1980 |
Cryptococcosis with cutaneous manifestations treated with 5-fluorocytosine.
Topics: Child, Preschool; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Immunity; Skin; Skin Diseas | 1980 |
Oral cryptococcosis in a patient with AIDS. A case report.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Dental Care for Chronically I | 1995 |
[A case of primary pulmonary cryptococcosis associated with pneumothorax].
Topics: Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Lung Diseases, Fungal; Pneumotho | 1995 |
Cryptococcosis after renal transplantation.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Kidney Transplantation; Mal | 1995 |
Cryptococcosis, AIDS, and clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Resistance; Drug Therapy, C | 1995 |
Hepatic involvement culminating in cirrhosis in a child with disseminated cryptococcosis.
Topics: Amphotericin B; Child; Cholestasis, Extrahepatic; Cryptococcosis; Flucytosine; Hepatitis; Humans; Li | 1995 |
Cryptococcus neoformans vertebral osteomyelitis.
Topics: Aged; Amphotericin B; Antigens, Fungal; Biopsy; Cryptococcosis; Cryptococcus neoformans; Drug Therap | 1994 |
[Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine].
Topics: Aged; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Drug Synergism; Drug Ther | 1993 |
Disseminated lymphonodular cryptococcosis in a child with X-linked hyper-IgM immunodeficiency.
Topics: Agammaglobulinemia; Amphotericin B; Child, Preschool; Cryptococcosis; Drug Therapy, Combination; Flu | 1994 |
Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Cat Diseases; Cats; Cryptococcosi | 1996 |
Cryptococcosis: an unusual cause of endobronchial obstruction.
Topics: Adult; Amphotericin B; Antifungal Agents; Bronchial Diseases; Bronchoscopy; Cryptococcosis; Flucytos | 1996 |
Unusual presentation of cryptococcosis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; An | 1996 |
Cryptococcosis as an opportunistic infection in immunodeficiency secondary to paracoccidioidomycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Flucytosine; Humans; Immunologic Deficienc | 1996 |
[Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neofor | 1996 |
Suspected drug eruption in seven dogs during administration of flucytosine.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cryptococcosis; Dog Diseases; Dogs; Drug | 1996 |
Cryptococcal cellulitis in an immunocompetent host.
Topics: Aged; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Dermatomycoses; Female; Flucona | 1997 |
Acute cerebellopathy as a probable toxic effect of flucytosine.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cerebellar Diseases; Cryptococcosis; Female; Flucytosine | 1997 |
Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro.
Topics: Animals; Antibodies, Monoclonal; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; | 1996 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
Presumed multifocal cryptococcol choroidopathy prior to specific systemic manifestation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Choroiditis; Cryptococ | 1997 |
[A cured case of primary pulmonary cryptococcosis with cryptococcal meningitis].
Topics: Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Lung Diseases, Funga | 1985 |
Cryptococcosis at the University Hospital, Kuala Lumpur.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combinatio | 1998 |
Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen.
Topics: Administration, Oral; Aged; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Fluconazol | 1998 |
Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Flucytos | 1998 |
Idiopathic CD4+ T-lymphocytopenia in a child with disseminated cryptococcosis.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Bone Marrow; Child, Preschool; Cryptococcosis; | 1998 |
Eyelid nodule: a sentinel lesion of disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cry | 1999 |
First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cry | 1998 |
[Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome].
Topics: Acute Disease; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Analy | 1999 |
[Meningitis by Cryptococcus neoformans in patients with HIV infection].
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Com | 1999 |
Massive pleural effusions in cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Female; Flucytosine; Humans; Meningitis, C | 1999 |
Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, | 1999 |
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus | 2000 |
Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; C | 2000 |
Cryptococcal osteomyelitis of the spine.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agent | 1999 |
Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Diseas | 2001 |
[Visceral mycotic infections. In clinical practice].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasm | 2001 |
Successful treatment of cryptococcal osteomyelitis and paraspinous abscess with fluconazole and flucytosine.
Topics: Abscess; Adult; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; F | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cr | 2001 |
Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; An | 2002 |
Treatment of cryptococcosis.
Topics: Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Flucytosine; Humans; Menin | 1979 |
Comparative study of trichothecin, amphotericin B, and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Disease Mo | 1977 |
[Amphotericin B and 5-fluorocytosine treatment in renal transplant recipient with cryptococcal meningitis (author's transl)].
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Flucytosine; Humans; Kidney Transplantation; Male; | 1977 |
In vitro and in vivo studies on synergistic antifungal activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococ | 1977 |
5-Fluorocytosine--current status with special references to mode of action and drug resistance.
Topics: Aspergillosis; Candida albicans; Candidiasis; Chromoblastomycosis; Cryptococcosis; Cytosine; Drug Re | 1977 |
Cryptococcosis: a diagnostic challenge.
Topics: Agglutination Tests; Amphotericin B; Antibodies, Fungal; Cryptococcosis; Cryptococcus neoformans; Di | 1977 |
Cryptococcal endophthalmitis after corneal transplantation.
Topics: Adult; Aged; Amphotericin B; Corneal Transplantation; Cryptococcosis; Endophthalmitis; Female; Flucy | 1978 |
Interaction of chemotherapy and immune defenses in experimental murine cryptococcosis.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Immunity, Cel | 1978 |
Recent advances in the treatment of systemic mycotic infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; | 1979 |
[Cryptococcal meningoencephalitis with extremely high C.S.F. gamma-globulin and immunoglobulin (author's transl)].
Topics: Aged; Amphotericin B; Chronic Disease; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Different | 1979 |
[Cryptococcosis of the central nervous system: evaluation of amphotericin-B, 5-fluorocytosine and miconazole therapy in 18 cases].
Topics: Adolescent; Adult; Amphotericin B; Central Nervous System Diseases; Child, Preschool; Cryptococcosis | 1979 |
Localized osseous cryptococcosis.
Topics: Amphotericin B; Cervical Vertebrae; Cryptococcosis; Flucytosine; Humans; Infant; Male; Osteomyelitis | 1979 |
Disseminated lymphonodular cryptococcosis treated with 5-fluorocytosine.
Topics: Administration, Oral; Child; Cryptococcosis; Cytosine; Flucytosine; Humans; Lymph Nodes; Lymphatic D | 1979 |
Short-term combination chemotherapy for treatment of feline cryptococcosis.
Topics: Administration, Oral; Amphotericin B; Animals; Cat Diseases; Cats; Cryptococcosis; Drug Therapy, Com | 1979 |
Treatment of cryptococcal meningitis.
Topics: Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Meningitis | 1979 |
Treatment of cryptococcal meningitis.
Topics: Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Meningitis | 1979 |
Crystalluria during flucytosine therapy.
Topics: Cryptococcosis; Crystallization; Cytosine; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle | 1979 |
[Iatrogenic mycoses with deep visceral localization caused by opportunistic fungi].
Topics: Amphotericin B; Candida; Candidiasis; Cryptococcosis; Dermatomycoses; Endocarditis; Flucytosine; Hum | 1979 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Candidiasis; Cryptococcosis; Cytosine; Flucytosine; Humans; Stilbamidines | 1977 |
Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Male; Meni | 1977 |
Cryptococcal meningitis. Fatal marrow aplasia from combined therapy.
Topics: Adult; Amphotericin B; Bone Marrow Diseases; Cryptococcosis; Cytosine; Drug Synergism; Drug Therapy, | 1978 |
Cryptococcosis: survival attributed to combination antifungal treatment.
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Mal | 1978 |
Disseminated Cryptococcus treated with transfer factor.
Topics: Abscess; Aged; Amphotericin B; Cryptococcosis; Flucytosine; Heart; Humans; Lung Abscess; Male; Remis | 1978 |
Trichosporon cutaneum endocarditis.
Topics: Amphotericin B; Aortic Valve; Cryptococcosis; Cryptococcus; Endocarditis, Subacute Bacterial; Flucyt | 1978 |
Clinical problems with 5-fluorocytosine.
Topics: Adult; Candidiasis; Child; Child, Preschool; Cryptococcosis; Cytosine; Drug Antagonism; Drug Resista | 1978 |
Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity.
Topics: Capsules; Cryptococcosis; Cytosine; Flucytosine; Fluorouracil; Humans; Kidney; Meningitis | 1978 |
Case report: immunosuppressive therapy following Cryptococcal meningitis.
Topics: Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Immunosuppression Therapy; Kidne | 1976 |
Cryptococcosis after renal transplantation: report of ten cases.
Topics: Adult; Amphotericin B; Brain Diseases; Child; Cryptococcosis; Drug Administration Schedule; Female; | 1976 |
Simple assay for 5-fluorocytosine in the presence of amphotericin B.
Topics: Amphotericin B; Biological Assay; Candida albicans; Candidiasis; Cryptococcosis; Cytosine; Flucytosi | 1976 |
Multiple lymphonodular cryptococcosis, cured by 5-fluorocytosine.
Topics: Child, Preschool; Cryptococcosis; Cryptococcus neoformans; Cytosine; Female; Flucytosine; Humans; Ly | 1976 |
Cryptococcal meningitis complicating systemic lupus erythematosus: two patients treated with flucytosine and amphotericin B.
Topics: Amphotericin B; Cryptococcosis; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Fem | 1977 |
Cryptococcosis.
Topics: Adult; Amphotericin B; Child; Cryptococcosis; Female; Flucytosine; Humans; Lung Diseases, Fungal; Ma | 1977 |
Cryptococcal eye disease.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Eye Diseases; Flucytosine; Humans; Male | 1977 |
Cerebral cryptococcosis in Malaysia.
Topics: Adolescent; Adult; Brain Diseases; Child; Cryptococcosis; Female; Flucytosine; Humans; Malaysia; Mal | 1976 |
Combination antifungal therapy for cryptococcal meningitis.
Topics: Adult; Aged; Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Hodgk | 1976 |
Cryptococcosis (torulosis, European blastomycosis) of the knee joint. A case report with review of the literature.
Topics: Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Knee Joint; Radiography; Synovia | 1976 |
A case of cryptococcosis treated with 5-fluorocytosine.
Topics: Child, Preschool; Cryptococcosis; Cytosine; Female; Flucytosine; Humans | 1976 |
[Treatment of cryptococcal meningitis with 5-fluorocytosine. Report of 2 cases].
Topics: Adult; Aged; Cryptococcosis; Cytosine; Flucytosine; Humans; Male; Meningitis | 1975 |
Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Disease Mo | 1975 |
Immunologic studies in patients with sarcoidosis and cryptococcosis.
Topics: Amphotericin B; Candida; Cell Count; Cryptococcosis; Cryptococcus neoformans; Dinitrochlorobenzene; | 1975 |
Cryptococcal meningoencephalitis.
Topics: Adult; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Humans; La | 1975 |
[Cerebromeningeal cryptococcosis. Predisposing role of immunosuppressive therapy in patients with kidney transplants].
Topics: Adult; Amphotericin B; Brain Diseases; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; | 1975 |
Treatment of fungal infections with flucytosine.
Topics: Adult; Alkaline Phosphatase; Candida; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus ne | 1975 |
[Further experimental data on clotrimazole: effectiveness against Cryptococcus neoformans, Sporothrix schenkii and Blastomyces dermatitidis Gilchrist].
Topics: Amphotericin B; Animals; Blastomyces; Clotrimazole; Cryptococcosis; Cryptococcus; Cryptococcus neofo | 1975 |
Cryptococcal meningitis: diagnostic value of cryptococcal antigen in cerebrospinal fluid.
Topics: Adult; Amphotericin B; Antigens, Fungal; Autopsy; Cryptococcosis; Cryptococcus neoformans; Flucytosi | 1975 |
Fungal infection following renal transplantation.
Topics: Adolescent; Adult; Amphotericin B; Antibodies, Fungal; Aspergillosis; Bacterial Infections; Candidia | 1975 |
Diagnosis and treatment of cutaneous fungus diseases.
Topics: Actinomycosis; Amphotericin B; Blastomycosis; Candida albicans; Candidiasis, Cutaneous; Chromoblasto | 1975 |
Letter: Amphotericin B and 5-fluorocytosine.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Drug Syner | 1975 |
Invasive fungal infection in the immunosuppressed host.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillosis; Candidiasis; Clotrimazole; Cryptococcosis; Flu | 1975 |
Cryptococcal meningitis. Report on case successfully treated with 5-fluorocytosine.
Topics: Administration, Oral; Adult; Amphotericin B; Cryptococcosis; Cytosine; Flucytosine; Humans; Male; Me | 1975 |
Letter: Treatment of fungal infections.
Topics: Amphotericin B; Candidiasis; Cryptococcosis; Cytosine; Drug Therapy, Combination; Flucytosine; Human | 1975 |
Therapeutic usefulness. 5-Fluorocytosine--a new anti-fungal agent.
Topics: Adult; Aged; Amphotericin B; Candida; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; F | 1975 |
[Current problems and new developments in therapy of mycoses (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clotrimazole; Cryptococcosis; Dermatomycoses; Drug R | 1975 |
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.
Topics: Adult; Aged; Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; Flucytosin | 1975 |
[Amphotericin-B and 5-fluorocytosine in the treatment of cryptococcosis of the central nervous system].
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Drug Evaluation; Drug Therapy, Combination; Encepha | 1975 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, | 1992 |
Meningitis due to Prototheca wickerhamii in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cerebrospinal Fluid; Cryptococcosis; C | 1992 |
Cryptococcal osteomyelitis and cellular immunodeficiency associated with interleukin-2 deficiency.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; HLA Antigens; Hu | 1992 |
[Six cases of primary pulmonary cryptococcosis].
Topics: Adult; Aged; Biopsy; Bronchoscopy; Cryptococcosis; Female; Fluconazole; Flucytosine; Humans; Lung Di | 1992 |
Isolated ocular cryptococcosis in an immunocompetent patient.
Topics: Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Eye Infections, Fungal; Female; Flucytosine | 1992 |
[Cryptococcosis: presentation of 26 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Amphotericin B; Antigens, Fungal | 1992 |
Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii.
Topics: Adult; Amphotericin B; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Comb | 1992 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1992 |
Cavitary pulmonary cryptococcosis complicating Churg-Strauss vasculitis.
Topics: Amphotericin B; Churg-Strauss Syndrome; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Huma | 1992 |
Cryptococcal meningitis in a child with systemic lupus erythematosus.
Topics: Amphotericin B; Azathioprine; Cerebrospinal Fluid; Child; Cryptococcosis; Diagnosis, Differential; F | 1990 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Costs and Cost Analysis; C | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combinatio | 1990 |
Artifactual elevation of the serum creatinine in patients receiving flucytosine for cryptococcal meningitis.
Topics: Creatinine; Cryptococcosis; Flucytosine; Humans; Meningitis | 1991 |
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
Topics: Amphotericin B; Animals; Chromatography, Gas; Cryptococcosis; Drug Therapy, Combination; Fluconazole | 1991 |
[Drug therapy of intractable mycoses].
Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucy | 1990 |
[Cryptococcosis in Bujumbura, Burundi. Apropos of 80 observed cases in 42 months].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Burundi; Cryptococcosis; Drug Thera | 1990 |
The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus.
Topics: Amphotericin B; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Flucytosine; HIV Infectio | 1990 |
Treatment of cryptococcal meningitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Flucytosine; Humans; Meningitis | 1990 |
Treating systemic fungal infections in AIDS patients. Prolonging life against the odds.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Cryptoco | 1990 |
Is cryptococcal meningoencephalitis in the tropics a distinct entity? A retrospective study from Thailand.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Hum | 1990 |
Fluconazole success after amphotericin B and flucytosine failure in cryptococcal meningitis.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Male; Meningitis | 1990 |
Cryptococcal choroiditis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Fungal; Choroiditis; Cryptococc | 1990 |
[A case of systemic lupus erythematosus associated with cryptococcal meningitis which was successfully cured by the administration of massive dose of amphotericin B].
Topics: Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Infusions, In | 1990 |
CNS cryptococcosis: unusual aspects.
Topics: Adult; Aged; Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Female; Fluconazole; F | 1989 |
Cutaneous cryptococcosis resembling molluscum contagiosum: a first manifestation of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Cryptococcosis; Diagnosis, Differential; Flucytos | 1989 |
Cryptococcal meningitis: unusual manifestation in a young adult and management.
Topics: Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male; Meningitis | 1989 |
Cryptococcosis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Antibodies, Fungal; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Flucy | 1989 |
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neofor | 1989 |
Artifactual elevation of the serum creatinine in patients receiving flucytosine for cryptococcal meningitis.
Topics: Adult; Creatinine; Cryptococcosis; Cryptococcus neoformans; False Positive Reactions; Flucytosine; H | 1989 |
5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
Topics: Amphotericin B; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Microbial; F | 1989 |
Fungal peritonitis in children on continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Amphotericin B; Candidiasis; Child; Child, Preschool; Cryptococcosis; Female; Flucytosin | 1989 |
Granulocytopenia and thrombocytopenia associated with combination therapy of amphotericin B and low-dose flucytosine in a patient with cryptococcal meningitis.
Topics: Adult; Agranulocytosis; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Huma | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1987 |
Cryptococcosis in AIDS patients: observations concerning CNS involvement.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male | 1989 |
Cryptococcal meningoencephalitis presenting transient focal cerebral symptoms.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Focal Infection; Humans; Ischemic Attack, Transient; Ma | 1989 |
[Amphotericin B in the treatment of neurocryptococcosis in patients subjected to renal transplantation].
Topics: Adolescent; Adult; Aged; Amphotericin B; Central Nervous System Diseases; Child; Child, Preschool; C | 1988 |
[A case of successfully treated cryptococcal meningitis, complicated with aplastic anemia].
Topics: Adult; Amphotericin B; Anemia, Aplastic; Cryptococcosis; Flucytosine; Humans; Male; Meningitis | 1988 |
Treatment of cryptococcal meningitis with high-dose, long-term combination amphotericin B and flucytosine.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; | 1988 |
Cryptococcal meningoencephalitis with parkinsonian features.
Topics: Aged; Aged, 80 and over; Amphotericin B; Basal Ganglia Diseases; Cryptococcosis; Flucytosine; Humans | 1988 |
Parenteral 5-fluorocytosine in the therapy of systemic mycoses.
Topics: Amphotericin B; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Infant, | 1988 |
[Central nervous cryptococcosis giving rise to ascites after ventriculo-peritoneal shunting--a case report].
Topics: Ascites; Brain Diseases; Cerebrospinal Fluid Shunts; Cryptococcosis; Female; Flucytosine; Humans; Hy | 1988 |
Cryptococcal meningitis in AIDS patients. A two-case report.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, | 1988 |
[Cryptococcosis in renal transplantation. A report of 4 cases].
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Immunosuppression Th | 1988 |
Treatment of cryptococcal meningitis.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Meningitis | 1988 |
Fatal disseminated cryptococcosis following intraocular involvement.
Topics: Adult; Amphotericin B; Cryptococcosis; Flucytosine; Fundus Oculi; Humans; Male; Meningitis; Predniso | 1988 |
Treatment of intraventricular cryptococcal granuloma: correction.
Topics: Brain Diseases; Cryptococcosis; Flucytosine; Granuloma; Humans | 1988 |
Isolated Cryptococcus neoformans osteomyelitis in an immunocompetent child.
Topics: Amphotericin B; Child; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Ilium | 1988 |
Cryptococcal aortitis.
Topics: Amphotericin B; Aortitis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Male; Midd | 1988 |
[Case of autoimmune hemolytic anemia complicated by cryptococcal meningitis during therapy of neutropenia].
Topics: Agranulocytosis; Amphotericin B; Anemia, Hemolytic, Autoimmune; Cryptococcosis; Female; Flucytosine; | 1988 |
Mycological-diagnostic assessment of the efficacy of amphotericin B + flucytosine to control Cryptococcus neoformans in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Dose-Response Relationshi | 1988 |
Peripheral eosinophilia in the course of treatment of cryptococcal meningitis.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Eosinophilia; Female; | 1987 |
[Meningeal cryptococcosis].
Topics: Adult; Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Male; Meningitis; Miconazole | 1987 |
Cryptococcal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antigens, Fungal; Cryptococcosis; Cryptococcus n | 1986 |
[Clinical and therapeutic studies in eleven cases of primary pulmonary cryptococcosis].
Topics: Adolescent; Adult; Aged; Biopsy; Cryptococcosis; Diagnosis, Differential; Female; Flucytosine; Human | 1987 |
Cryptococcal infections of the central nervous system: a ten year experience.
Topics: Adult; Aged; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Meningitis; Middle Aged; Prognosis | 1987 |
[Acute disseminated cryptococcosis disclosing AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Amphotericin B; Cryptococcosis; Flucytosin | 1987 |
Management of cryptococcosis and toxic epidermal necrolysis in a dog.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Dog Diseases; Dogs; Drug Therapy, Combin | 1987 |
Surgery in combined pulmonary and neural cryptococcosis.
Topics: Adult; Combined Modality Therapy; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Male; | 1987 |
[Disseminated cryptococcosis in 2 AIDS patients. A contribution to cryptococcosis diagnosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male | 1986 |
Cryptococcal meningoencephalitis. Case report and review of Italian literature.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male; Meningoencephalitis; Tomograp | 1986 |
[A case of systemic lupus erythematosus with cryptococcal meningitis successfully treated with amphotericin B and 5-FC].
Topics: Adult; Amphotericin B; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Hum | 1986 |
Cryptococcal infection of the central nervous system.
Topics: Adult; Amphotericin B; Brain; Brain Diseases; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fu | 1985 |
[Acute lymphocytic leukemia, complicated with generalized cryptococcosis successfully treated by amphotericin B; a case report].
Topics: Amphotericin B; Cryptococcosis; Female; Flucytosine; Humans; Leukemia, Lymphoid; Middle Aged | 1985 |
Cure of cryptococcal infection during continued immunosuppressive therapy.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantati | 1985 |
Cryptococcosis in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antibodies, Fungal; Antigens, Fungal; Cryptococc | 1985 |
Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Brain Diseases; Cryptococcosis; Drug Ther | 1986 |
Exotic infection in the immunocompromised host.
Topics: Aged; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunosuppression Therapy; Male; Nephroti | 1986 |
[Cryptococcus neoformans meningoencephalitis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination | 1986 |
[Cryptococcal meningitis].
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Resistance, Microbial; Drug Therapy, | 1986 |
Cryptococcal infection of the central nervous system.
Topics: Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Flucytosine; Humans; Meningitis; Pr | 1985 |
Spastic paraparesis due to cryptococcal osteomyelitis. A case report.
Topics: Amphotericin B; Combined Modality Therapy; Cryptococcosis; Flucytosine; Humans; Male; Middle Aged; M | 1985 |
Intracerebral cryptococcomas.
Topics: Adolescent; Adult; Brain Diseases; Cerebral Angiography; Cryptococcosis; Female; Flucytosine; Humans | 1985 |
Falsely elevated serum creatinine levels secondary to the presence of 5-fluorocytosine.
Topics: Aged; Creatinine; Cryptococcosis; Cytosine; False Positive Reactions; Flucytosine; Humans; Male | 1985 |
Cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Cryptococcosis; Flucytosine; Follow-Up Studies; Garl | 1985 |
Cryptococcal meningitis: presentation as sudden deafness.
Topics: Amphotericin B; Audiometry, Evoked Response; Cryptococcosis; Electronystagmography; Evoked Potential | 1985 |
Ocular involvement in the acquired immune deficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis, Oral; Cryptococcosis; Eyelid | 1985 |
Antibiotics, 1972.
Topics: Amino Sugars; Anti-Bacterial Agents; Bacteria; Candidiasis; Carbenicillin; Cephalosporins; Cryptococ | 1972 |
[Cryptococcosis of the central nervous system with cellular immune reaction disorders].
Topics: Antifungal Agents; Benzene Derivatives; Central Nervous System Diseases; Child; Cryptococcosis; Fema | 1974 |
[Generalized primary cryptococcosis. Immunological study and medico-surgical treatment].
Topics: Amphotericin B; Antibodies; Complement System Proteins; Cryptococcosis; Flucytosine; Humans; Immunit | 1974 |
Cryptococcal meningitis--treated with 5-fluorocytosine and amphotericin B (a case report).
Topics: Amphotericin B; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Meningitis; Middle Aged | 1974 |
Flucytosine therapy in cryptococcosis. Report of a case.
Topics: Antifungal Agents; Child; Cryptococcosis; Cytosine; Flucytosine; Humans; Male | 1972 |
The treatment of systemic cryptococcosis with 5-fluorocytosine.
Topics: Adult; Cerebral Ventricles; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Lung Diseases, Fu | 1974 |
Editorial: Cryptococcosis and 5-fluorocytosine.
Topics: Amphotericin B; Animals; Cryptococcosis; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combina | 1974 |
Chemotherapy of the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; H | 1973 |
Treatment of multiple intracerebral cryptococcal granulomas with 5-fluorocytosine. Case report.
Topics: Adult; Antifungal Agents; Brain; Brain Diseases; Cryptococcosis; Cryptococcus neoformans; Cytosine; | 1972 |
The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Cytosine; Dose- | 1973 |
5-Fluorocytosine resistance in candida spp. and Torulopsis glabrata.
Topics: Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis; Cryptococcosis; Cytosine; Dr | 1973 |
Cryptococcal meningitis in pregnancy.
Topics: Adolescent; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Flucytosine; Hum | 1972 |
Fatal aplastic anemia resulting from flucytosine.
Topics: Administration, Oral; Anemia, Aplastic; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; | 1974 |
Cryptococcal osteomyelitis treated with 5-fluorocytosine.
Topics: Aged; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Curettage; Cytosine; Female; Flucy | 1974 |
Nasal cryptococcosis.
Topics: Amphotericin B; Antibodies, Fungal; Biopsy; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neofor | 1974 |
Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
Topics: Amphotericin B; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Cytosine; Drug Resistance, Mi | 1974 |
Therapy of deep-seated fungal infections with 5-fluorocytosine.
Topics: Adult; Aged; Amphotericin B; Anterior Chamber; Aspergillosis; Aspergillus fumigatus; Candida albican | 1974 |
A note on treatment for cryptococcal meningitis.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Meningitis | 1973 |
Treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cr | 1973 |
Clinical results with a new antifungal agent.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Chromoblastomycosis; Cryptococcosis; Cytosine; | 1974 |
Cryptococcal meningitis: a case treated with 5-fluorocytosine.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Cytosine; Female; Flucytosine; Humans; Meni | 1974 |
Cryptococcal hepatitis mimicking primary sclerosing cholangitis. A case report.
Topics: Adult; Amphotericin B; Biopsy; Cholangitis; Cryptococcosis; Diagnostic Errors; Flucytosine; Granulom | 1974 |